hg_102088.1

Basic information about the TSS

---

TSS ID: hg_102088.1 Species: human Chr: chr9		Start: 113187987 End: 113188001 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AK301208 Distance: -46 GeneID: 23307 HGNC/MGI_ID: HGNC:23397 UniProt_ID: B4DVS2

Gene_name: FKBP prolyl isomerase family member 15 Gene_symbol: FKBP15 Gene_synonyms: FKBP133 PPP1R76 WAFL Gene_source: HGNC:23397

TATA-Box annotation

---

Distance to TSS:	33283
Nearest PromoterID:	NM_015258
Entrez ID:	23307
Nearest Unigene:	Hs.522351
Nearest Refseq:	NM_015258
Nearest Ensembl:	ENSG00000119321
Gene Name:	FKBP prolyl isomerase family member 15
Gene Alias:	FKBP133|KIAA0674|PPP1R76
Gene Description:	FKBP prolyl isomerase 15
Gene Type:	protein-coding
CpG%:	0
GC%:	0.462687
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@FKBP15 p3@FKBP15 p4@FKBP15 p5@FKBP15 p6@FKBP15 p7@FKBP15 p8@FKBP15 p9@FKBP15
Sample		p1@FKBP15	p3@FKBP15	p4@FKBP15	p5@FKBP15	p6@FKBP15	p7@FKBP15	p8@FKBP15	p9@FKBP15
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	3.31	1.36	0.00	2.73	0.00	0.00	0.97	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	3.64	3.24	0.00	1.21	0.00	0.00	2.02	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	5.21	3.28	0.00	1.93	0.00	0.00	1.54	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	2.70	1.87	0.00	2.29	0.00	0.00	1.66	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	3.82	2.02	0.00	2.92	0.00	0.00	1.12	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	4.65	0.97	0.00	1.36	0.00	0.00	0.97	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	9.59	3.49	0.00	1.53	0.00	0.00	1.74	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	4.60	2.66	0.24	2.91	0.00	0.00	1.70	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	4.70	2.78	0.00	0.85	0.00	0.00	2.56	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	8.11	2.90	0.00	4.06	0.00	0.00	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	8.89	4.45	0.00	1.62	0.00	0.00	2.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.98	2.03	0.00	3.25	0.00	0.00	1.63	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	10.32	7.09	1.13	0.16	0.00	0.16	1.77	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	11.13	5.71	1.35	0.30	0.00	0.15	2.10	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.88	7.03	1.54	0.22	0.00	0.00	3.07	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	7.04	4.02	1.26	0.25	0.00	0.00	1.01	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	9.83	5.68	1.97	0.00	0.00	0.00	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.55	2.11	1.69	0.00	0.00	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.53	2.67	1.07	0.00	0.00	0.00	1.60	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	11.28	5.57	2.41	0.00	0.00	0.30	2.71	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	6.95	5.08	1.34	0.27	0.00	0.00	1.34	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	8.63	7.08	1.55	0.00	0.00	0.17	1.73	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.57	4.65	1.68	0.13	0.00	0.39	1.55	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	10.68	4.13	1.46	0.00	0.00	0.00	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	6.45	3.10	2.06	0.00	0.00	0.00	1.55	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.13	5.06	0.95	0.32	0.00	0.00	0.32	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	11.54	4.95	1.10	0.00	0.55	0.00	2.75	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	15.32	4.95	1.89	0.00	0.00	0.00	3.77	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.50	5.33	1.13	0.32	0.00	0.00	2.75	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	10.68	6.33	0.90	0.00	0.00	0.00	4.89	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.30	4.61	0.84	0.00	0.00	0.21	2.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	10.16	5.86	1.37	0.00	0.00	0.20	2.93	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.29	5.06	0.84	0.00	0.00	0.00	1.48	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	12.70	4.62	1.98	0.00	0.00	0.33	3.96	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	9.91	3.74	1.87	0.00	0.00	0.00	2.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	11.88	3.26	0.77	0.19	0.00	0.00	2.49	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.22	4.91	0.82	0.00	0.00	0.00	3.68	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	8.66	4.03	0.81	0.00	0.00	0.20	3.02	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.69	4.32	2.16	0.27	0.00	0.27	5.40	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	12.00	4.32	1.20	0.00	0.00	0.00	4.08	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.29	3.06	0.24	0.24	0.00	0.00	3.76	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11.71	4.54	0.88	0.15	0.00	0.00	3.07	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	13.92	5.06	0.21	0.21	0.21	0.21	3.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.94	4.55	0.52	0.52	0.00	0.00	2.27	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	13.05	4.62	1.20	0.60	0.00	0.00	3.81	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	12.80	5.58	0.93	0.00	0.00	0.00	7.21	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	13.91	4.32	1.92	0.00	0.00	0.00	5.76	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.05	3.58	1.19	0.00	0.00	0.00	7.45	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.88	5.03	1.91	0.72	0.00	0.24	5.03	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	18.20	5.66	1.01	0.40	0.00	0.20	5.46	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	17.01	4.10	0.61	1.02	0.00	0.00	3.28	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	19.35	7.56	0.44	0.44	0.00	0.00	3.56	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	27.98	13.99	0.00	0.00	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	17.39	6.03	0.35	0.00	0.00	0.00	2.13	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	15.24	4.64	0.66	0.66	0.00	0.00	3.31	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	34.40	4.19	4.19	0.00	0.00	0.00	24.33	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	26.64	7.35	1.38	0.00	0.00	0.00	6.43	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	14.58	4.86	1.30	0.65	0.00	0.00	2.92	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	10.92	5.14	0.32	0.00	0.00	0.00	3.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	29.23	6.60	1.26	0.00	0.00	0.00	10.69	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	17.63	7.05	0.71	0.00	0.00	0.00	2.82	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.78	2.80	0.00	0.56	0.56	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	40.60	4.78	0.80	0.00	0.00	0.00	16.72	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	20.39	5.78	0.68	0.00	0.00	0.00	4.42	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	15.27	4.22	0.65	0.32	0.00	0.00	2.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.84	2.48	0.00	0.35	0.00	0.00	2.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	16.16	16.16	0.00	0.00	0.00	64.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	7.90	0.00	0.00	0.00	0.00	63.18	31.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	12.19	3.90	0.00	0.00	0.00	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	16.86	2.98	0.99	0.00	0.00	0.00	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	11.73	4.22	0.47	0.00	0.00	0.00	1.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	17.55	3.97	0.33	0.00	0.00	0.00	2.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	15.78	2.78	0.00	0.31	0.00	0.00	1.24	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	14.06	5.81	0.31	0.31	0.00	0.00	1.83	0.61
Adipocyte - breast, donor1	11376-118A8	12.83	6.02	2.38	0.48	0.00	0.32	2.22	2.53
Adipocyte - breast, donor2	11327-117E4	9.47	4.33	1.93	0.32	0.00	0.16	2.57	1.12
Adipocyte - omental, donor1	11473-119C6	12.85	6.23	1.65	0.89	0.00	0.25	2.42	2.29
Adipocyte - omental, donor2	11474-119C7	6.73	2.99	1.49	0.75	0.00	0.00	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	11.72	3.35	0.33	0.67	0.00	0.00	8.04	1.67
Adipocyte - perirenal, donor1	11476-119C9	10.21	4.47	0.00	0.64	0.00	0.00	9.57	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	0.00	1.10	0.00	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	14.45	2.71	4.97	0.00	0.00	0.00	1.81	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	8.52	2.43	0.52	0.35	0.00	0.00	1.39	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	15.06	6.65	4.89	0.98	0.00	0.39	7.43	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	13.90	3.86	4.63	1.54	0.26	0.26	2.83	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	16.17	5.58	6.69	0.56	0.00	0.00	3.07	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	9.40	5.29	5.29	0.00	0.00	0.00	2.94	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	15.36	6.92	4.42	1.61	0.00	0.24	4.34	0.97
Adipocyte differentiation, day08, donor2	13023-139D8	18.72	7.42	6.78	1.29	0.97	0.65	1.29	2.90
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	6.40	7.46	1.60	1.07	0.00	1.60	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	7.79	3.90	3.90	0.00	0.00	0.00	1.67	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	7.90	5.41	1.25	1.25	0.42	0.00	1.66	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	17.08	6.78	5.53	0.50	1.00	0.50	0.75	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	11.78	3.27	4.58	0.65	0.00	0.00	0.98	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	10.35	5.78	5.18	0.61	0.00	0.61	0.61	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	9.28	4.42	0.00	0.66	0.00	0.00	3.31	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	5.38	0.72	0.00	0.36	0.00	0.00	1.08	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	9.36	7.56	0.18	0.18	0.00	0.00	1.98	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	9.86	7.40	0.21	0.21	0.00	0.00	1.44	0.41
Anulus Pulposus Cell, donor1	11248-116E6	9.04	6.06	0.11	0.23	0.00	0.00	5.95	1.26
Anulus Pulposus Cell, donor2	11463-119B5	7.84	2.94	0.00	0.00	0.00	0.00	4.90	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	10.33	4.04	0.90	0.00	0.00	0.00	2.70	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	9.55	3.47	0.00	0.00	0.00	0.43	4.34	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	0.00	0.00	0.00	0.00	0.00	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.37	2.09	2.39	0.00	0.00	0.30	2.69	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	2.53	0.00	0.00	0.00	0.00	3.79	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	1.98	1.32	0.66	0.00	0.00	1.98	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.47	2.27	0.65	0.00	0.32	0.32	1.30	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.19	2.91	1.46	0.00	0.00	0.00	2.43	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	2.97	2.38	1.19	0.00	0.00	0.00	2.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	7.91	3.77	1.51	0.00	0.00	0.00	2.64	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	2.18	2.18	0.00	0.73	0.00	0.00	2.90	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1.25	1.25	3.76	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	7.74	3.79	1.48	0.00	0.00	0.00	1.65	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	1.36	1.36	0.00	0.00	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.37	2.11	0.90	0.75	0.00	0.15	1.96	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.18	4.82	1.07	1.07	0.00	0.54	2.14	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	6.42	3.02	0.76	0.00	0.00	0.19	5.10	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.88	4.81	0.53	0.27	0.00	0.27	1.07	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	0.00	0.98	0.00	0.00	0.00	3.90	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	4.81	3.98	0.66	0.33	0.00	0.00	4.81	1.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	3.60	1.20	0.00	0.00	0.00	2.40	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	3.54	0.00	0.00	0.00	0.00	10.62	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.03	3.26	0.86	0.51	0.00	0.17	4.80	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	11.65	3.40	0.49	0.00	0.00	0.00	4.85	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.49	4.55	1.90	0.00	0.00	0.00	7.97	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	4.85	0.00	0.00	0.00	0.00	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.12	2.28	1.14	0.57	0.00	0.00	3.99	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	5.34	2.78	0.86	0.43	0.00	0.00	2.78	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.16	3.61	0.26	0.26	0.00	0.00	1.29	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.69	3.28	0.94	0.47	0.00	0.00	3.28	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	6.43	2.89	0.96	0.64	0.00	0.00	1.93	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	0.71	1.43	0.71	0.00	0.00	0.00	0.71	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	3.51	1.75	1.17	0.00	0.00	0.00	2.34	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.32	2.71	0.60	0.00	0.00	0.30	1.51	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	2.38	2.38	0.00	0.00	0.00	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	7.12	2.03	1.53	0.00	0.00	0.00	3.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.37	2.55	2.29	0.00	0.00	0.25	3.31	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1.91	3.18	0.64	0.00	0.00	0.00	1.91	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.04	2.59	0.86	1.29	0.00	0.00	1.73	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4.23	3.18	0.85	0.21	0.00	0.21	4.45	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.67	1.74	0.00	0.58	0.00	0.00	1.16	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	4.72	2.83	1.89	0.00	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	5.09	2.03	0.68	0.00	0.00	0.17	3.39	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	0.00	4.63	0.00	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	2.11	4.23	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	6.00	2.57	0.86	0.00	0.00	0.00	1.93	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	5.41	3.01	0.60	0.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	7.29	2.19	0.00	0.00	0.00	0.00	2.92	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	6.67	4.37	0.69	0.23	0.00	0.00	2.99	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	0.00	0.00	0.00	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.58	2.03	1.27	0.00	0.00	0.25	1.53	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	7.23	4.13	0.83	0.00	0.00	0.00	2.89	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.04	2.75	0.61	0.61	0.00	0.00	0.92	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	6.69	2.87	1.43	0.96	0.00	0.00	2.87	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.65	3.33	0.89	0.22	0.00	0.00	3.55	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	3.05	1.53	0.00	0.00	0.00	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	3.32	3.88	0.00	0.00	0.00	0.55	5.54	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	6.88	2.91	0.79	0.53	0.00	0.00	3.71	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.82	3.63	0.73	0.00	0.00	0.00	1.45	0.00
Astrocyte - cerebellum, donor1	11500-119F6	9.95	5.16	0.00	0.74	0.00	0.00	6.88	0.86
Astrocyte - cerebellum, donor2	11580-120F5	7.70	2.74	0.00	0.00	0.00	0.00	3.08	0.51
Astrocyte - cerebellum, donor3	11661-122F5	4.82	4.40	0.21	0.00	0.00	0.00	0.63	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	12.90	10.46	0.00	1.74	0.00	0.00	6.27	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	9.71	8.57	0.16	0.97	0.00	0.00	3.56	2.10
Astrocyte - cerebral cortex, donor3	11392-118C6	10.74	9.10	0.00	0.75	0.00	0.00	4.33	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	43.47	15.02	0.00	1.61	0.00	0.00	1.26	1.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	37.84	13.41	0.00	1.50	0.00	0.00	2.00	1.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	38.69	16.05	0.00	1.93	0.00	0.00	1.48	1.02
Basophils, donor1	12241-129G9	22.75	3.14	21.71	4.71	3.14	5.23	0.52	0.26
Basophils, donor2	12242-129H1	23.81	5.77	22.01	4.69	2.16	2.53	1.80	0.36
Basophils, donor3	12243-129H2	20.87	6.32	18.37	2.79	2.06	3.09	1.03	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	6.04	3.02	0.43	0.22	0.00	0.00	0.65	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	5.49	1.83	0.00	0.00	0.00	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	8.79	1.88	0.63	1.26	0.00	0.00	10.04	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	10.61	3.95	1.04	0.62	0.00	0.21	3.33	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	8.52	1.84	2.53	0.23	0.00	0.00	1.15	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	5.76	1.98	0.54	0.00	0.00	0.00	1.26	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	32.98	9.48	0.00	1.85	0.00	0.00	3.50	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	57.99	10.25	0.00	1.63	0.00	0.00	4.66	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	7.99	6.72	0.00	0.32	0.00	0.00	4.80	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00	0.00	20.68	0.00
CD14+ Monocytes, donor1	11224-116B9	36.63	6.76	21.98	2.25	2.25	5.07	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	28.21	4.27	7.61	1.30	0.56	1.11	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	27.44	6.81	8.34	1.98	1.98	3.07	0.00	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	162.47	25.47	25.47	13.59	16.70	1.42	0.57	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	105.38	16.30	36.39	12.51	7.58	2.65	1.90	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	140.04	21.04	22.03	17.09	14.14	2.30	1.31	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	52.62	7.66	36.57	5.49	32.67	8.24	0.87	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	32.29	3.92	48.28	4.22	26.25	10.26	1.21	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	52.59	7.11	28.43	5.92	21.32	5.69	1.18	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	31.30	3.35	41.51	6.03	22.26	9.37	0.50	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	15.46	2.21	48.30	5.24	17.66	12.14	1.10	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	21.82	3.47	61.49	6.20	17.60	11.90	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	23.69	3.52	63.44	3.72	18.41	7.83	1.96	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	26.71	2.85	69.80	3.38	25.10	15.31	3.38	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	23.29	1.96	98.37	4.79	17.85	15.67	6.31	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	36.76	2.58	102.08	7.49	11.47	27.63	0.23	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	29.04	2.11	113.53	4.75	20.07	23.23	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	22.19	0.00	71.00	12.20	14.42	15.53	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	36.89	3.27	42.99	4.16	25.14	10.41	1.19	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	32.13	2.59	60.06	2.99	26.94	11.77	0.80	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	31.02	3.33	49.97	3.33	20.61	9.58	1.04	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	27.23	2.52	82.59	4.12	13.96	14.41	0.23	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	22.17	2.49	107.90	2.04	19.23	19.91	1.58	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	22.26	2.18	64.60	3.06	8.29	10.91	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	39.00	6.46	22.86	2.96	13.72	4.30	2.15	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	34.19	3.14	40.65	4.71	21.63	8.03	3.14	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	36.19	4.21	30.30	2.10	20.20	3.79	2.95	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	29.58	0.92	79.00	1.65	6.43	11.39	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	22.54	0.00	75.38	2.47	5.64	9.16	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	18.43	0.88	62.74	0.88	6.58	7.90	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	22.84	2.96	76.72	9.59	25.28	15.34	1.05	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	18.96	3.35	94.78	4.83	23.79	18.96	1.86	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	22.85	4.74	127.82	10.78	25.43	33.63	4.10	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	20.88	3.28	66.34	3.28	8.60	5.32	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	19.24	2.55	135.37	2.32	10.66	20.40	0.70	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	20.65	0.70	75.86	3.71	8.58	13.22	0.00	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	59.94	8.06	7.19	2.40	13.08	0.44	0.87	1.74
CD14+CD16+ Monocytes, donor2	11801-124D1	60.06	10.16	3.93	1.85	4.85	1.15	0.92	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	45.71	8.88	7.58	2.17	7.15	0.65	1.08	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	100.13	14.79	5.61	6.85	9.34	0.62	0.47	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	67.59	11.18	2.79	5.06	4.72	0.70	0.52	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	141.14	16.28	8.92	7.14	10.26	0.22	0.45	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	50.27	8.17	6.38	3.83	14.80	0.00	0.00	1.53
CD14-CD16+ Monocytes, donor2	11800-124C9	46.99	12.08	4.17	2.85	8.56	0.22	0.44	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	52.85	8.84	9.69	3.16	20.42	0.63	0.42	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	6.10	0.00	0.00	0.00	0.00	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	12.20	12.20	0.00	1.36	0.68	0.00	2.03	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	21.75	13.46	0.00	0.00	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	16.52	13.33	1.07	1.07	1.60	0.00	2.13	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	28.95	17.15	0.00	0.54	0.00	0.00	2.68	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	18.95	12.63	0.00	0.70	0.00	0.00	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	23.53	10.98	0.78	1.57	0.00	0.00	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	15.82	10.55	0.00	0.00	0.00	0.00	3.95	0.00
CD19+ B Cells, donor1	11544-120B5	23.84	11.51	0.00	0.82	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	8.71	5.08	0.00	0.73	0.00	0.00	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	13.13	5.05	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	39.19	20.20	0.00	4.04	0.00	0.00	1.62	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	23.97	13.58	0.00	2.80	0.00	0.00	2.00	1.20
CD34+ Progenitors, donor1	11545-120B6	4.02	3.01	0.00	0.00	0.00	0.00	3.01	2.01
CD34+ Progenitors, donor2	11625-122B5	2.81	2.81	2.81	0.00	0.56	1.69	2.25	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	13.53	7.52	0.00	2.25	0.38	0.00	8.27	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	16.01	10.82	0.23	1.80	0.23	0.00	5.64	0.90
CD4+ T Cells, donor1	11225-116C1	19.64	8.93	0.00	2.14	0.00	0.00	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	7.35	7.35	0.00	1.22	0.00	0.00	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	11.28	7.32	0.00	0.30	0.00	0.00	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	25.52	13.27	0.00	0.51	0.00	0.00	3.57	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	20.21	14.82	0.00	0.90	0.00	0.00	1.12	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	20.12	13.22	0.00	0.57	0.00	0.00	1.72	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	14.22	11.85	0.00	1.42	0.00	0.00	0.00	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	14.05	18.26	0.00	0.70	0.00	0.00	1.40	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	23.07	0.00	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	27.02	9.68	0.00	1.45	0.00	0.00	2.60	1.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	16.10	10.00	0.00	0.34	0.00	0.00	0.85	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	15.80	9.83	0.00	0.97	0.00	0.00	1.77	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	12.55	10.76	0.00	2.24	0.00	0.00	2.24	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	11.53	12.23	0.00	0.70	0.00	0.00	1.75	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	23.76	16.72	0.00	0.88	0.00	0.00	2.20	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	32.04	13.49	0.00	0.00	0.00	0.00	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	13.51	9.97	0.00	0.21	0.00	0.00	0.62	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	17.04	11.03	0.00	0.33	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	24.20	22.30	0.00	2.72	0.00	0.00	1.09	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	20.90	19.29	0.00	0.00	0.00	0.00	1.07	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	21.52	16.14	0.00	0.00	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	25.03	14.65	0.00	0.93	0.00	0.00	1.48	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	24.48	13.00	0.00	0.43	0.00	0.00	1.73	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	22.49	11.56	0.00	1.68	0.00	0.00	1.47	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	13.65	18.71	0.00	1.01	0.00	0.00	2.53	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	12.13	9.53	0.00	2.60	0.00	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	31.38	17.87	0.00	0.87	0.00	0.44	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	22.27	21.77	0.00	1.48	0.49	0.00	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	11.08	14.77	0.00	0.92	0.00	0.00	3.69	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	25.12	16.75	0.00	1.40	0.00	0.00	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	36.28	17.17	0.55	1.66	0.55	0.00	5.82	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	41.96	19.63	0.49	1.47	0.00	0.00	3.68	1.47
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	21.56	21.56	0.00	0.00	1.54	0.00	3.08	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	31.51	26.86	1.07	3.58	0.72	0.00	2.15	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	26.31	13.85	0.00	0.00	0.00	0.00	2.77	1.38
CD8+ T Cells, donor1	11226-116C2	14.08	9.17	0.00	2.29	0.00	0.00	1.31	0.33
CD8+ T Cells, donor2	11307-117C2	10.14	6.01	0.00	0.75	0.00	0.00	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	12.12	7.07	0.25	2.78	0.00	0.00	0.76	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	6.88	2.52	0.00	1.15	0.00	0.00	1.38	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	4.31	2.88	0.00	0.96	0.00	0.00	1.68	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	8.75	1.92	0.00	2.74	0.00	0.00	3.01	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	7.21	3.60	0.00	1.20	0.00	0.00	4.20	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.72	3.60	0.00	1.68	0.00	0.00	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	5.91	3.64	0.00	0.00	0.00	0.00	1.36	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	6.52	3.04	0.00	0.87	0.00	0.00	1.74	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	6.84	2.11	0.00	0.79	0.00	0.00	3.42	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	6.33	3.05	0.00	0.70	0.00	0.00	3.52	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	8.15	1.51	0.00	0.91	0.00	0.00	2.42	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	4.94	2.03	0.00	0.00	0.00	0.00	1.74	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	4.80	2.93	0.00	0.00	0.00	0.00	2.13	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	4.82	2.19	0.00	3.50	0.00	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	3.19	3.64	0.00	2.73	0.00	0.00	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	2.98	1.49	0.00	0.75	0.00	0.00	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.76	1.80	0.00	0.72	0.00	0.00	1.80	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	6.04	2.30	0.00	2.30	0.00	0.00	1.44	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.96	2.59	0.00	1.18	0.00	0.00	0.94	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	5.07	5.39	0.00	0.32	0.00	0.00	3.49	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.00	2.46	0.00	0.92	0.00	0.00	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.13	3.85	0.00	0.32	0.00	0.00	0.96	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	3.82	2.68	0.00	1.53	0.00	0.00	1.53	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	6.31	3.15	0.00	1.18	0.00	0.00	1.58	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7.56	2.27	0.00	0.76	0.00	0.00	2.27	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	8.03	0.80	0.00	1.61	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	7.69	2.10	0.00	2.80	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	16.03	3.01	0.00	1.00	0.00	0.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	12.79	3.66	0.00	0.00	0.00	0.00	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	4.45	2.96	0.49	0.49	0.00	0.00	3.95	0.49
Cardiac Myocyte, donor3	11686-122I3	11.47	4.00	0.11	0.42	0.00	0.00	7.05	0.95
Chondrocyte - de diff, donor1	11261-116G1	9.71	4.85	0.35	1.04	0.00	0.00	5.20	3.12
Chondrocyte - de diff, donor2	11338-117F6	12.44	7.46	0.36	0.36	0.00	0.00	3.55	1.42
Chondrocyte - de diff, donor3	11410-118E6	5.46	4.89	0.23	0.11	0.00	0.00	3.19	0.68
Chondrocyte - re diff, donor2	11339-117F7	20.59	12.53	1.79	2.69	0.00	0.00	7.16	0.90
Chondrocyte - re diff, donor3	11411-118E7	9.30	6.07	0.00	0.00	0.00	0.00	4.85	3.24
Ciliary Epithelial Cells, donor1	11242-116D9	11.82	8.26	0.11	0.69	0.00	0.00	5.16	1.38
Ciliary Epithelial Cells, donor2	11323-117D9	5.77	5.13	0.00	0.21	0.00	0.00	4.92	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	7.96	5.22	0.00	0.35	0.00	0.00	4.25	1.33
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	18.16	13.30	0.73	1.56	0.64	0.18	1.74	1.01
Corneal Epithelial Cells, donor1	11526-119I5	4.39	2.63	0.00	0.22	0.00	0.00	0.88	0.44
Corneal Epithelial Cells, donor2	11606-120I4	10.24	2.28	0.00	0.00	0.00	0.00	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	6.39	3.58	0.00	0.51	0.00	0.00	1.53	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	25.42	7.43	11.72	2.48	2.15	0.50	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	27.76	6.62	9.46	2.52	1.58	0.32	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	6.90	0.00	0.00	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	32.94	7.56	10.04	2.16	2.59	0.43	0.32	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	20.16	8.20	0.34	0.34	0.00	0.00	1.37	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	18.93	9.14	0.00	0.00	0.00	0.00	3.26	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	15.49	7.26	0.97	0.00	0.48	0.00	1.45	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	13.68	7.50	0.67	1.00	0.00	0.33	1.50	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	4.11	3.52	1.17	0.00	0.00	0.00	2.93	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	9.33	3.68	0.57	0.28	0.00	0.28	4.24	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	6.29	5.50	0.39	0.39	0.00	0.00	1.97	0.00
Endothelial Cells - Artery, donor1	11264-116G4	5.24	4.36	0.87	0.58	0.29	0.00	6.40	1.75
Endothelial Cells - Artery, donor2	11341-117F9	10.82	5.88	0.47	0.24	0.00	0.00	2.59	0.47
Endothelial Cells - Artery, donor3	11413-118E9	8.24	5.61	0.35	0.35	0.00	0.00	1.93	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	11.97	7.09	2.88	0.44	0.66	0.00	1.77	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	17.95	5.48	4.87	0.00	2.13	0.30	1.83	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	12.40	6.77	0.56	0.28	0.85	0.00	4.23	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	9.51	2.38	0.30	0.00	0.30	0.00	4.75	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	13.02	5.73	1.04	0.00	0.00	0.52	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	5.81	2.55	0.00	0.00	0.00	0.00	1.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	18.81	4.00	0.80	0.40	0.00	0.00	7.20	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	8.91	3.14	0.00	0.00	0.00	0.00	3.14	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	18.76	10.31	0.37	0.99	0.25	0.00	6.46	4.22
Endothelial Cells - Umbilical vein, donor2	11324-117E1	16.29	9.13	0.65	1.52	0.00	0.00	2.39	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	12.21	7.94	0.24	0.61	0.00	0.00	4.52	0.73
Endothelial Cells - Vein, donor1	11267-116G7	2.28	1.14	0.00	0.00	0.00	0.00	2.28	2.28
Endothelial Cells - Vein, donor2	11344-117G3	6.99	3.49	0.00	0.70	0.00	0.00	2.79	1.40
Endothelial Cells - Vein, donor3	11416-118F3	6.59	4.40	0.16	0.79	0.16	0.00	5.02	1.10
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	31.35	3.30	0.00	3.30	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	35.67	0.00	3.57	3.57	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.89	2.93	0.00	0.00	0.00	0.00	2.20	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.14	5.75	0.00	0.00	0.00	0.00	3.28	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.35	2.74	2.19	0.33	0.00	0.00	1.20	0.66
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	5.85	3.03	0.11	0.33	0.00	0.00	2.93	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	10.31	5.82	1.21	1.33	0.00	0.00	2.06	1.46
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	30.16	10.78	9.96	2.05	0.00	1.50	1.23	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.91	3.27	1.90	0.32	0.00	0.11	2.74	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	24.50	6.85	2.11	1.58	0.00	0.00	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	12.96	5.32	0.00	1.33	0.00	0.00	3.65	1.33
Fibroblast - Cardiac, donor1	11268-116G8	5.90	4.08	1.36	0.45	0.00	0.00	5.44	2.27
Fibroblast - Cardiac, donor2	11345-117G4	9.10	3.03	0.00	0.00	0.00	0.00	0.76	1.52
Fibroblast - Cardiac, donor3	11417-118F4	5.05	4.10	0.95	0.32	0.00	0.32	1.73	0.47
Fibroblast - Cardiac, donor4	11452-119A3	9.70	9.40	0.91	1.21	0.00	0.00	4.24	1.82
Fibroblast - Cardiac, donor5	11456-119A7	12.69	6.60	1.14	0.51	0.00	0.00	7.36	1.52
Fibroblast - Cardiac, donor6	11460-119B2	9.25	5.00	0.91	1.06	0.00	0.15	7.73	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	16.35	7.10	0.13	0.80	0.00	0.00	6.03	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	6.04	4.75	0.00	0.86	0.00	0.00	5.18	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	5.86	2.93	0.00	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	10.61	5.07	0.00	0.23	0.00	0.00	2.54	1.38
Fibroblast - Conjunctival, donor3	11692-122I9	10.01	8.82	0.68	0.34	0.00	0.00	5.26	3.73
Fibroblast - Dermal, donor1	11269-116G9	5.40	1.41	6.34	0.00	0.00	0.23	2.35	0.70
Fibroblast - Dermal, donor2	11346-117G5	9.43	3.30	2.83	0.94	0.00	0.00	3.77	0.94
Fibroblast - Dermal, donor3	11418-118F5	5.68	3.87	1.21	0.12	0.00	0.00	2.42	1.33
Fibroblast - Dermal, donor4	11450-119A1	10.63	6.56	0.11	0.68	0.00	0.00	2.37	1.47
Fibroblast - Dermal, donor5	11454-119A5	14.31	7.15	0.17	0.35	0.00	0.00	3.66	1.74
Fibroblast - Dermal, donor6	11458-119A9	17.05	5.52	0.16	1.14	0.00	0.00	4.39	0.65
Fibroblast - Gingival, donor1	11237-116D4	13.74	9.58	2.71	0.42	0.00	0.00	5.21	2.29
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	23.32	11.27	0.26	1.05	0.00	0.00	2.10	1.31
Fibroblast - Gingival, donor2	11318-117D4	8.04	6.19	0.66	0.66	0.00	0.00	2.90	1.84
Fibroblast - Gingival, donor3	11394-118C8	10.54	7.93	1.64	0.48	0.00	0.00	2.61	2.03
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	20.78	5.19	2.08	3.12	0.00	0.00	7.27	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	9.51	3.88	1.23	1.23	0.00	0.00	2.47	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	15.12	7.64	0.00	1.71	0.00	0.00	2.96	1.40
Fibroblast - Gingival, donor6 (control)	11922-125H5	14.60	7.98	1.62	1.35	0.00	0.14	2.03	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.59	4.59	1.06	1.06	0.00	0.35	0.71	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	12.28	9.21	1.46	1.46	0.00	0.00	2.63	2.05
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	16.09	8.18	1.23	1.09	0.00	0.00	1.91	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	14.59	7.68	1.32	2.41	0.00	0.00	1.65	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	17.46	9.98	0.15	0.88	0.00	0.00	1.76	0.73
Fibroblast - Lung, donor1	11270-116H1	6.80	2.72	1.36	0.00	0.00	0.00	4.08	0.00
Fibroblast - Lung, donor2	11347-117G6	4.48	2.98	0.00	1.49	0.00	0.00	4.48	2.98
Fibroblast - Lung, donor3	11419-118F6	6.33	2.95	0.84	0.21	0.00	0.00	2.53	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	10.83	3.33	0.83	2.50	0.00	0.83	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	4.20	1.40	0.00	1.40	0.00	4.20	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	5.04	1.40	0.56	0.00	0.00	0.00	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	22.33	7.71	2.44	0.81	0.00	0.00	2.03	0.81
Fibroblast - Mammary, donor2	11620-122A9	11.98	0.00	3.99	0.00	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	11.91	0.00	0.00	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	13.38	9.12	0.19	0.39	0.00	0.00	2.91	1.94
Fibroblast - Periodontal Ligament, donor2	11319-117D5	14.56	7.28	0.15	0.61	0.00	0.00	2.28	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	20.20	11.32	3.67	1.22	0.00	0.31	3.67	2.45
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	11.07	5.72	0.38	1.14	0.00	0.00	1.91	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.23	4.05	0.81	0.81	0.00	0.00	2.70	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	8.81	6.03	1.51	0.46	0.00	0.12	2.90	1.16
Fibroblast - Pulmonary Artery, donor1	11250-116E8	10.28	3.87	0.22	0.66	0.00	0.00	4.75	2.87
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	9.96	5.08	1.22	1.02	0.00	0.00	3.05	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.02	4.68	0.00	0.67	0.00	0.67	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	3.16	1.58	0.00	0.79	0.00	0.00	2.37	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	29.97	10.52	0.00	3.18	0.00	0.40	1.19	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	8.35	6.39	0.53	1.07	0.00	0.00	3.37	1.24
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	15.77	7.29	0.79	1.38	0.00	0.00	4.34	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	29.78	10.83	0.30	1.50	0.00	0.00	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	20.29	8.20	0.54	1.19	0.00	0.00	5.94	1.40
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	33.41	8.10	0.00	2.02	0.00	0.00	0.51	0.76
Fibroblast - skin normal, donor1	11553-120C5	13.62	7.22	0.82	0.66	0.00	0.00	4.59	1.64
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	37.09	14.64	0.60	5.01	0.00	0.40	1.80	0.60
Fibroblast - skin normal, donor2	11561-120D4	22.60	6.73	0.10	1.21	0.00	0.00	5.32	1.91
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	48.66	16.32	0.30	1.81	0.00	0.00	2.42	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	19.22	8.95	0.33	1.16	0.00	0.00	2.73	1.16
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	15.39	9.06	0.51	0.68	0.00	0.00	11.45	2.91
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.03	10.84	0.33	2.30	0.00	0.00	1.97	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	14.27	6.39	0.32	1.38	0.00	0.00	4.58	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	17.37	8.60	0.00	1.01	0.00	0.00	5.40	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	11.60	3.61	0.16	0.31	0.00	0.00	10.82	4.70
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	22.16	0.00	0.00	0.00	0.00	66.48	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	23.53	12.20	0.00	0.87	0.00	0.00	1.74	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.97	3.29	6.76	0.35	0.00	1.21	2.08	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	8.85	6.25	6.77	0.52	0.00	0.52	3.12	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	15.33	4.60	3.83	0.51	0.00	0.77	4.09	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	4.59	6.12	0.00	0.00	0.00	0.00	5.36	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	10.21	3.83	0.00	0.64	0.00	0.00	5.74	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	13.69	7.42	0.00	1.71	0.00	0.00	18.26	3.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	12.96	10.20	0.00	0.28	0.00	0.00	8.00	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	12.10	5.25	0.00	0.00	0.00	0.00	4.11	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	9.71	5.15	0.00	0.00	0.00	0.00	8.52	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	12.16	5.55	0.00	0.00	0.00	0.00	7.93	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	12.07	9.78	0.00	0.33	0.00	0.00	4.89	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	7.08	5.75	0.00	1.77	0.00	0.00	11.94	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	8.90	4.80	0.00	0.00	0.00	0.00	5.37	1.41
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	10.59	3.94	0.00	0.37	0.00	0.00	3.69	1.35
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5.91	5.37	0.00	0.54	0.00	0.00	3.76	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	8.80	4.21	0.37	0.25	0.00	0.00	5.70	1.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	8.31	3.88	0.55	0.28	0.00	0.00	5.68	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	7.52	3.66	0.41	0.41	0.00	0.00	3.25	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	8.67	4.79	0.91	0.00	0.00	0.00	3.65	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	9.97	4.24	1.00	0.25	0.00	0.12	4.61	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	8.09	5.46	0.00	0.44	0.00	0.00	4.59	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	10.34	5.02	0.00	0.30	0.00	0.00	3.55	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	10.17	2.86	0.00	0.16	0.00	0.00	5.09	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	10.05	4.24	0.00	0.00	0.00	0.00	2.46	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	7.66	4.84	0.20	0.60	0.00	0.00	4.23	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	9.84	3.90	0.51	0.17	0.00	0.00	5.77	2.37
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	13.03	7.09	0.89	0.80	0.00	0.18	5.94	0.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.82	10.09	0.21	0.10	0.00	0.00	4.16	1.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	14.17	8.37	0.17	0.17	0.00	0.00	4.10	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	10.62	4.76	0.22	0.44	0.00	0.00	4.65	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	12.73	8.57	1.00	0.42	0.00	0.08	4.83	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.68	8.17	1.63	0.82	0.00	0.20	6.53	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	8.66	5.57	0.00	0.41	0.00	0.00	5.57	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	10.49	4.61	0.12	0.46	0.00	0.00	6.11	1.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	14.01	7.50	1.67	0.00	0.00	0.00	4.00	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	10.58	5.95	0.00	0.66	0.00	0.00	3.75	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	10.70	4.92	0.00	0.25	0.00	0.00	3.94	1.72
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	11.99	6.32	0.81	0.16	0.00	0.00	4.38	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.30	3.21	0.00	0.00	0.00	0.00	4.81	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	11.94	4.74	0.09	0.38	0.00	0.00	3.41	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	10.76	6.96	0.32	0.16	0.00	0.00	2.69	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	10.03	7.91	0.00	0.61	0.00	0.00	5.47	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.56	5.33	0.21	0.42	0.00	0.10	4.70	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	11.42	5.05	0.22	0.66	0.00	0.00	3.07	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	11.22	8.98	0.00	0.56	0.00	0.00	3.65	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.67	5.28	0.28	0.37	0.00	0.00	2.31	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	12.03	4.55	0.80	1.07	0.00	0.00	2.41	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	9.49	6.73	1.38	0.46	0.00	0.00	2.60	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	9.84	4.27	0.78	0.26	0.00	0.00	3.37	1.17
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	20.33	5.42	0.00	0.54	0.00	0.00	3.52	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	11.98	5.90	0.00	0.18	0.00	0.00	3.69	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	8.77	4.82	0.22	0.22	0.00	0.00	2.85	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	24.79	9.92	0.00	0.99	0.00	0.00	4.96	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	9.76	5.28	0.13	0.79	0.00	0.00	2.24	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	11.70	5.65	0.00	0.61	0.00	0.00	2.02	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	25.92	16.27	0.00	1.27	0.00	0.00	3.05	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	12.34	3.18	0.00	0.20	0.00	0.00	13.74	1.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	7.86	3.70	0.00	0.31	0.00	0.00	3.54	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	10.64	5.73	0.00	0.20	0.00	0.00	9.82	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5.01	3.76	0.00	0.31	0.00	0.00	10.01	2.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	5.65	2.54	0.00	0.00	0.00	0.00	11.58	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	7.38	6.00	0.00	0.46	0.00	0.00	9.69	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	2.47	0.00	0.00	0.00	0.00	14.85	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	5.42	4.64	0.00	1.16	0.00	0.00	15.09	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	1.60	0.00	1.60	0.00	0.00	3.21	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	13.91	3.48	0.00	0.00	0.00	0.00	12.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	5.21	4.88	0.00	0.00	0.00	0.00	10.74	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	9.06	3.71	0.00	1.65	0.00	0.00	14.41	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	0.00	0.00	0.00	0.00	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	6.99	4.75	0.00	0.28	0.00	0.00	8.95	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	5.88	2.61	0.00	0.00	0.00	0.00	8.50	2.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	7.55	10.07	0.00	0.84	0.00	0.00	9.23	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	6.04	6.68	0.00	0.32	0.00	0.00	9.86	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	5.43	5.43	0.00	0.34	0.00	0.00	7.47	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	0.00	12.53	0.00	0.00	0.00	0.00	12.53	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	6.87	8.59	0.00	0.00	0.00	0.00	8.02	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	5.62	3.85	0.00	0.59	0.00	0.00	7.40	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	5.08	3.39	0.00	0.00	0.00	0.00	11.86	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	9.53	4.97	0.00	1.24	0.00	0.00	11.18	3.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	8.74	5.98	0.00	0.46	0.00	0.00	9.44	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	10.54	0.00	0.00	0.00	0.00	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	6.92	2.31	0.00	0.38	0.00	0.00	8.07	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	8.80	6.52	0.00	0.33	0.00	0.00	8.15	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	4.68	6.69	0.00	0.00	0.00	0.00	8.69	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	9.63	8.09	0.00	1.16	0.00	0.00	7.71	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	10.27	8.90	0.00	3.42	0.00	0.00	6.50	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	7.45	2.48	0.00	0.00	0.00	0.00	4.97	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	7.55	6.13	0.00	0.00	0.00	0.00	5.19	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	2.41	5.43	0.00	0.60	0.00	0.00	7.85	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	9.16	9.66	0.00	0.00	0.00	0.00	7.12	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	5.58	8.38	0.00	1.20	0.00	0.00	6.38	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	7.89	7.89	0.00	0.00	0.00	0.00	9.37	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	17.71	9.44	0.00	0.00	0.00	0.00	10.62	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	8.75	8.75	0.00	0.00	0.00	0.00	11.67	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	6.58	5.27	0.00	0.00	0.00	0.00	7.02	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	5.93	5.93	0.00	0.85	0.00	0.00	6.78	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	4.18	5.97	0.00	0.00	0.00	0.00	4.78	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	5.34	5.34	0.00	0.00	0.00	0.00	9.22	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	3.42	0.00	0.00	0.00	0.00	9.13	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	7.90	2.91	0.00	0.42	0.00	0.00	2.91	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	6.75	2.25	2.25	0.00	0.00	0.00	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	9.83	2.22	0.32	0.63	0.00	0.32	2.85	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.51	2.51	0.42	0.84	0.00	0.00	1.67	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	9.17	5.80	0.00	0.23	0.00	0.00	0.81	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	8.27	4.73	0.00	0.68	0.00	0.00	1.01	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	9.33	5.69	0.00	0.91	0.00	0.00	1.37	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	10.38	5.03	0.00	1.42	0.00	0.00	1.75	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	7.95	4.94	0.00	1.07	0.00	0.00	1.29	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	6.67	3.44	0.00	1.29	0.00	0.00	1.29	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	7.97	2.99	0.00	0.75	0.12	0.12	1.99	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	6.00	3.95	0.00	0.34	0.00	0.00	1.54	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	4.49	3.84	0.00	0.64	0.00	0.00	1.28	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	9.51	5.04	0.56	0.00	0.00	0.00	2.24	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.63	3.03	0.00	0.43	0.00	0.00	1.73	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	5.29	5.29	0.00	0.00	0.00	5.29	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.35	4.23	0.00	0.71	0.00	0.00	3.53	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.81	2.18	0.00	0.73	0.00	0.00	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6.82	3.67	0.52	0.87	0.00	0.00	4.20	1.57
Hepatocyte, donor1	11523-119I2	15.74	7.26	1.21	2.42	1.21	0.00	3.63	0.00
Hepatocyte, donor2	11603-120I1	10.77	6.46	0.00	1.08	3.23	0.00	7.54	1.08
Hepatocyte, donor3	11684-122I1	17.79	9.82	0.61	2.45	0.61	0.00	1.23	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	16.32	9.79	0.00	1.96	0.00	0.00	5.22	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	13.28	14.33	0.35	0.00	0.00	0.00	5.42	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	10.15	5.08	0.55	1.10	0.00	0.00	4.53	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	41.39	9.55	0.00	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	8.31	0.00	0.00	0.00	0.00	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	2.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	25.63	0.00	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	9.14	0.00	0.00	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	24.36	19.49	0.00	1.62	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	11.67	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	3.63	0.00	0.00	0.00	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	23.82	19.85	0.00	1.32	0.00	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	6.65	6.65	0.00	2.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	31.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	18.90	8.19	0.00	0.63	0.00	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	20.11	4.64	0.00	0.00	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	16.15	10.34	0.65	0.65	0.00	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	19.32	0.00	3.22	0.00	0.00	1.61	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	20.37	9.78	0.00	0.00	0.00	0.00	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	20.99	8.82	0.00	2.10	0.00	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	20.09	7.23	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	16.62	3.69	0.00	1.85	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	10.86	4.25	0.00	1.42	0.00	0.00	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	12.70	7.26	0.00	2.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	19.37	12.91	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	16.52	15.25	0.00	1.27	0.00	0.00	2.54	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	0.00	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	29.33	12.12	0.00	2.55	0.00	0.00	1.28	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	14.58	7.29	0.00	1.82	0.00	0.00	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	27.85	11.43	0.00	1.43	0.00	0.00	1.43	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	6.64	0.00	0.00	0.00	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	18.21	7.72	0.00	0.31	0.00	0.00	1.85	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	28.10	22.83	0.00	3.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	6.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	23.64	13.91	0.00	1.39	0.00	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	4.43	0.00	2.21	0.00	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	9.73	0.00	0.00	0.00	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	21.80	12.21	0.00	1.74	0.00	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	18.00	20.25	0.00	6.75	0.00	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	17.07	11.73	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	29.09	9.70	0.00	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	11.40	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	13.81	10.12	0.00	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	12.10	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	12.42	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	17.98	8.46	1.06	0.00	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	13.71	3.18	6.53	0.57	0.00	0.98	0.90	0.73
Keratinocyte - epidermal, donor2	11349-117G8	4.69	0.59	4.10	0.00	0.00	0.59	0.00	1.17
Keratinocyte - epidermal, donor3	11421-118F8	6.91	4.73	3.12	0.57	0.00	0.00	3.41	0.76
Keratinocyte - oral, donor1	11251-116E9	12.03	8.06	0.91	0.34	0.00	0.23	3.75	1.14
Keratocytes, donor1	11527-119I6	8.25	6.88	1.03	0.00	0.00	0.00	3.78	1.03
Keratocytes, donor2	11607-120I5	7.03	2.34	1.17	1.17	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	4.94	5.73	0.00	0.20	0.00	0.00	2.37	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	19.78	13.19	0.00	0.00	0.00	0.00	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	6.47	3.24	0.00	0.00	0.00	0.00	3.24	1.08
Lens Epithelial Cells, donor2	11609-120I7	8.19	6.57	0.00	0.12	0.00	0.00	7.27	4.04
Lens Epithelial Cells, donor3	11690-122I7	11.71	5.15	0.50	0.40	0.00	0.00	4.34	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	15.53	4.74	1.19	0.83	0.00	0.00	4.51	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.54	3.07	0.28	0.56	0.00	0.00	1.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	15.74	5.04	0.31	0.31	0.16	0.00	2.52	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.45	2.69	0.54	0.00	0.00	0.00	3.76	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.66	2.84	0.95	0.00	0.00	0.00	1.58	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	10.46	3.13	0.22	0.22	0.00	0.00	2.80	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.98	2.46	0.41	0.00	0.00	0.00	4.92	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	10.62	2.78	0.00	0.51	0.00	0.00	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.29	4.36	0.42	0.00	0.00	0.00	2.25	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.12	1.58	1.98	0.40	0.00	0.40	2.77	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.17	2.33	0.19	0.39	0.00	0.00	2.13	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.74	2.59	0.00	0.00	0.00	0.00	1.67	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	7.32	4.18	1.39	0.00	0.00	0.35	2.44	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	9.30	5.25	0.00	0.24	0.00	0.00	2.15	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	10.30	3.57	0.96	0.14	0.00	0.00	1.65	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.01	3.08	0.92	0.00	0.00	0.00	2.46	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.48	2.18	0.62	0.31	0.00	0.00	2.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.26	5.12	0.18	0.00	0.00	0.00	2.01	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.92	2.30	0.66	0.33	0.00	0.00	2.30	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.98	3.51	0.00	0.00	0.00	0.00	2.64	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.47	2.74	0.00	0.25	0.00	0.00	1.24	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.79	2.42	1.45	0.48	0.00	0.00	1.94	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.08	4.04	0.54	0.00	0.00	0.00	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.66	3.78	0.45	0.00	0.00	0.00	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.81	5.70	0.52	0.52	0.00	0.00	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	9.21	3.77	0.84	0.63	0.00	0.21	1.88	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.02	2.11	0.15	0.30	0.00	0.00	1.35	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	9.63	2.06	0.00	0.00	0.00	0.00	8.94	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.09	1.13	0.38	0.38	0.00	0.00	1.51	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.01	5.20	0.11	0.53	0.00	0.00	1.70	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	5.81	3.39	0.00	0.00	0.00	0.00	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.61	4.63	0.33	0.33	0.00	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.80	4.34	0.12	0.37	0.00	0.00	2.11	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	10.37	4.44	1.11	0.00	0.00	0.00	4.81	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.42	2.22	0.25	0.74	0.00	0.00	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.42	2.75	0.00	0.00	0.00	0.00	1.37	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	13.19	4.50	1.29	0.00	0.00	0.00	3.22	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.61	3.35	0.61	0.30	0.00	0.00	0.91	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.80	4.76	0.14	0.56	0.00	0.00	3.78	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	10.31	4.98	0.71	0.00	0.00	0.36	3.56	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.30	0.97	1.45	0.48	0.00	0.00	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	9.34	2.33	0.31	0.16	0.16	0.00	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	10.39	3.22	1.07	0.00	0.00	0.00	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.47	5.55	0.65	0.00	0.00	0.00	2.61	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.59	3.30	0.24	0.47	0.00	0.00	1.18	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.73	5.69	1.86	0.50	0.00	0.25	3.09	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.17	2.05	0.26	0.77	0.00	0.26	1.54	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.07	3.28	0.60	0.00	0.00	0.00	3.28	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	13.60	0.00	0.00	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	13.04	9.21	0.00	0.77	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	8.16	10.39	0.00	0.74	0.00	0.00	4.45	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.42	10.16	0.00	0.85	0.00	0.00	1.27	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4.92	8.44	0.70	0.00	0.00	0.00	0.00	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	5.60	7.47	0.00	0.00	0.00	0.00	3.74	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.82	9.79	0.00	1.03	0.00	0.00	0.00	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4.76	4.76	0.00	1.19	0.00	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.95	9.95	0.00	0.45	0.00	0.00	2.94	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.47	12.80	0.00	1.16	0.00	0.00	1.16	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	8.10	6.75	0.00	2.25	0.00	0.00	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	13.41	12.33	0.00	1.35	0.00	0.00	1.35	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.30	8.73	0.00	0.51	0.00	0.00	2.05	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	9.88	8.82	0.00	0.71	0.00	0.00	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.66	4.00	0.00	0.67	0.00	0.00	3.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	13.75	11.72	0.00	1.02	0.00	0.00	2.04	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	9.87	8.27	0.00	0.27	0.00	0.00	2.13	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	10.39	10.01	0.00	0.38	0.00	0.00	3.59	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	11.04	12.27	0.00	0.00	0.00	0.00	3.68	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	7.34	17.94	0.00	0.00	0.00	0.00	3.26	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	11.45	10.62	0.00	0.83	0.00	0.00	1.67	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	11.21	10.37	0.00	0.28	0.00	0.00	2.24	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	11.33	0.00	1.03	0.00	0.00	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	9.29	11.03	0.00	2.03	0.00	0.00	2.03	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.16	7.47	0.00	0.30	0.00	0.00	0.90	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.85	3.87	0.00	0.55	0.00	0.00	3.87	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	12.02	14.14	0.00	0.71	0.00	0.00	2.12	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	10.33	12.17	0.00	0.74	0.00	0.00	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	13.82	13.82	0.00	0.00	0.00	0.00	4.61	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.06	13.05	0.00	1.54	0.00	0.00	2.69	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	8.49	12.45	0.57	0.00	0.00	0.00	1.13	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	7.38	10.67	0.00	0.00	0.00	0.00	2.46	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	12.65	10.85	0.45	0.45	0.00	0.00	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.90	13.64	0.00	0.72	0.00	0.00	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	2.99	11.95	0.00	2.24	0.00	0.00	5.98	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	11.52	11.15	0.00	0.00	0.00	0.00	2.60	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.46	11.20	0.00	0.43	0.00	0.00	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.99	13.70	0.00	0.00	0.00	0.00	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	11.99	13.99	0.00	0.33	0.00	0.00	2.00	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	12.07	9.65	0.00	0.60	0.00	0.00	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.09	12.80	0.00	0.00	0.00	0.00	2.84	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	7.56	10.31	0.00	1.37	0.00	0.00	2.06	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	8.59	11.81	0.54	0.54	0.00	0.00	1.07	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.14	10.10	0.00	0.67	0.00	0.00	2.02	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	11.11	8.52	0.00	0.74	0.00	0.00	2.59	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	9.30	0.00	2.33	0.00	0.00	5.81	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	10.58	0.00	0.00	0.00	0.00	4.23	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	9.20	9.20	0.00	0.80	0.00	0.00	2.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	21.81	16.72	0.00	0.00	0.00	0.00	3.63	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.03	15.33	0.77	0.77	0.00	0.00	0.77	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	8.88	13.32	0.00	1.97	0.00	0.00	3.95	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	11.29	14.11	0.00	0.00	0.00	0.00	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	7.54	13.07	0.00	1.01	0.00	0.00	2.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.36	8.56	0.00	1.80	0.00	0.00	1.35	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	6.88	0.00	0.00	0.00	0.00	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	4.90	9.80	0.00	0.89	0.00	0.00	4.90	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	7.82	15.64	0.00	1.17	0.00	0.00	3.52	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	9.90	7.26	0.66	1.32	0.00	0.00	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	11.94	11.42	0.00	2.08	0.00	0.00	3.63	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	14.44	8.75	0.00	0.00	0.00	0.00	2.63	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.83	11.74	0.00	0.56	0.00	0.00	2.80	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	11.92	11.48	0.00	1.77	0.00	0.00	2.21	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	12.73	10.41	0.00	0.39	0.00	0.00	1.16	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	12.15	12.15	0.00	0.51	0.00	0.00	1.52	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	9.13	16.34	0.00	0.96	0.00	0.00	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	15.11	7.16	0.00	2.78	0.00	0.00	2.39	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	8.51	9.11	0.00	0.00	0.00	0.00	3.04	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	10.38	7.61	0.00	0.00	0.00	0.00	2.08	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	12.16	10.26	0.00	1.14	0.00	0.00	1.90	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	11.88	9.81	0.00	0.52	0.00	0.00	2.07	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	12.09	7.26	0.00	0.60	0.00	0.00	2.42	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12.04	10.77	0.00	0.95	0.00	0.00	2.22	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	17.06	11.73	0.00	0.53	0.00	0.00	2.67	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.34	5.17	0.00	0.57	0.00	0.00	2.30	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	13.37	13.88	0.00	0.51	0.00	0.00	2.57	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	12.73	12.03	0.00	0.71	0.00	0.00	2.83	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	17.59	9.08	0.00	1.70	0.00	0.00	6.24	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	14.98	12.90	0.00	0.83	0.42	0.00	1.66	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.09	15.66	0.00	3.92	0.00	0.00	0.78	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	15.45	9.60	0.00	1.67	0.00	0.00	5.43	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	9.29	13.47	0.00	0.93	0.00	0.00	2.79	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14.05	11.37	0.00	0.67	0.00	0.00	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	12.83	9.09	0.53	2.67	0.00	0.00	4.28	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	17.78	12.12	0.00	1.21	0.00	0.00	2.02	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	15.60	17.44	0.00	0.92	0.00	0.00	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	14.23	9.78	0.00	0.00	0.00	0.00	2.67	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.68	14.82	0.00	0.00	0.00	0.00	2.28	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	12.27	10.74	0.00	0.77	0.00	0.00	1.53	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	20.25	6.02	0.00	2.19	0.00	0.00	2.74	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	14.70	12.03	0.00	0.00	0.00	0.00	3.12	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	21.32	14.04	0.00	1.04	0.00	0.00	3.38	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	18.57	11.94	0.00	0.00	0.00	0.00	2.65	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	10.39	0.00	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	113.73	12.76	22.56	9.57	7.98	2.05	1.37	1.14
Macrophage - monocyte derived, donor2	11313-117C8	43.31	8.81	40.92	6.97	14.86	4.22	0.73	0.37
Macrophage - monocyte derived, donor3	11389-118C3	69.47	11.93	27.53	8.00	9.70	2.10	0.13	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	6.90	2.66	2.12	0.00	0.00	0.00	5.31	1.06
Mallassez-derived cells, donor2	11929-125I3	14.10	5.07	3.49	0.48	0.00	0.63	2.54	0.63
Mallassez-derived cells, donor3	11930-125I4	11.54	4.59	2.08	0.28	0.00	0.14	6.67	0.97
Mammary Epithelial Cell, donor1	11273-116H4	17.94	5.48	3.99	1.30	0.00	0.00	1.40	1.20
Mammary Epithelial Cell, donor2	11350-117G9	17.08	4.63	3.47	0.87	0.00	0.29	2.90	0.87
Mammary Epithelial Cell, donor3	11422-118F9	5.49	5.49	0.50	0.00	0.00	0.00	1.50	0.00
Mast cell - stimulated, donor1	11487-119E2	25.76	13.56	2.71	2.03	4.75	0.00	4.07	1.36
Mast cell, donor1	11563-120D6	18.28	10.81	1.19	0.76	0.11	0.11	1.41	0.76
Mast cell, donor2	11565-120D8	16.94	12.78	3.86	2.38	0.00	1.19	2.67	1.78
Mast cell, donor3	11566-120D9	25.44	18.69	6.98	1.35	0.23	0.23	1.13	1.13
Mast cell, donor4	11567-120E1	13.83	10.81	1.60	1.42	0.00	0.18	1.06	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	25.06	16.08	4.10	1.11	0.00	0.11	1.00	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	13.42	7.00	2.33	0.00	0.00	0.00	0.58	1.75
Mast cell, expanded, donor5	11939-126A4	17.67	13.31	2.41	1.15	0.34	0.11	1.72	0.11
Mast cell, expanded, donor8	11941-126A6	21.76	11.38	0.67	1.00	0.17	0.00	0.67	1.00
Melanocyte - dark, donor1	11502-119F8	11.24	3.58	0.00	0.30	0.00	0.00	6.67	0.70
Melanocyte - dark, donor2	11582-120F7	4.85	3.46	0.35	1.04	0.00	0.00	6.92	1.04
Melanocyte - dark, donor3	11663-122F7	21.51	9.06	1.74	0.72	0.00	0.00	4.42	2.46
Melanocyte - light, donor1	11274-116H5	10.34	5.88	5.64	0.71	0.00	0.24	1.18	0.94
Melanocyte - light, donor2	11351-117H1	12.28	3.41	1.36	0.00	0.00	0.68	4.09	0.00
Melanocyte - light, donor3	11423-118G1	9.54	5.20	0.87	0.87	0.00	0.00	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	14.89	5.62	2.81	0.21	0.00	0.10	5.10	1.56
Melanocyte, donor2 (MC+2)	12739-135I3	20.71	5.11	4.84	0.81	0.00	0.81	1.88	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	22.23	8.30	0.80	0.27	0.00	0.00	3.48	1.07
Meningeal Cells, donor1	11493-119E8	14.64	9.68	3.47	1.12	0.00	0.12	4.71	0.99
Meningeal Cells, donor2	11573-120E7	10.56	6.16	0.44	0.88	0.00	0.00	3.08	0.00
Meningeal Cells, donor3	11654-122E7	16.14	8.31	4.73	1.47	0.00	0.33	2.93	1.14
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	8.84	4.56	0.29	0.57	0.00	0.00	6.56	1.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	10.37	4.63	2.82	0.50	0.00	0.30	1.51	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	1.31	2.63	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	1.31	0.00	0.00	0.00	0.00	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	10.76	4.31	1.44	0.72	0.00	0.00	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	10.16	3.81	0.64	0.85	0.00	0.42	3.18	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	16.08	4.52	2.01	0.00	0.00	0.00	2.01	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	8.79	2.20	0.00	1.10	0.00	0.00	2.20	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	5.11	0.00	0.00	0.00	0.00	2.92	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.77	2.25	0.61	1.02	0.00	0.00	1.02	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	9.70	3.74	0.14	0.42	0.00	0.00	3.88	1.66
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.09	2.23	0.00	0.37	0.00	0.00	1.86	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	13.42	6.18	0.66	1.18	0.13	0.00	2.76	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.04	2.37	0.00	0.00	0.00	0.00	2.08	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	11.53	2.56	0.00	1.28	0.00	0.00	3.20	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	9.57	3.90	1.42	1.77	0.00	0.00	5.67	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	11.88	4.38	0.31	0.00	0.00	0.00	4.07	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	1.45	2.18	0.00	0.00	0.00	0.00	4.35	0.00
Mesothelial Cells, donor1	11247-116E5	12.20	7.69	17.24	1.33	0.27	3.98	1.33	2.39
Mesothelial Cells, donor2	12156-128G5	8.51	3.50	8.51	0.50	0.00	1.50	2.00	1.00
Mesothelial Cells, donor3	11402-118D7	10.12	6.87	6.72	0.51	0.00	0.94	1.37	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	62.11	9.45	12.15	18.90	6.75	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	93.58	10.84	14.28	7.63	12.81	2.22	0.74	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	58.89	13.55	15.02	7.66	12.96	1.77	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	48.40	6.91	3.46	10.37	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	67.26	8.06	13.95	6.82	8.37	1.24	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	43.15	8.71	16.59	5.39	13.07	1.24	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	53.27	11.58	2.32	2.32	4.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	59.31	6.76	20.27	9.01	13.01	1.00	0.75	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	55.86	10.71	13.96	8.38	9.78	0.47	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	47.96	8.33	19.31	3.66	9.96	1.02	0.41	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	39.20	8.32	11.88	3.96	13.86	1.58	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	111.17	25.65	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	30.09	7.08	30.09	0.88	2.65	2.65	1.77	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	44.83	3.80	14.06	6.08	12.16	1.52	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	38.16	5.26	0.00	1.32	1.32	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	41.81	7.64	16.77	3.40	6.58	1.49	0.64	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	34.99	3.68	3.68	2.76	8.29	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	31.89	5.66	9.54	3.58	5.07	0.89	0.30	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	85.51	10.06	0.00	0.00	6.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	29.36	4.27	11.79	4.52	6.77	1.00	0.75	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	33.99	5.94	10.46	4.04	6.65	0.71	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	18.80	2.21	2.21	2.76	1.11	1.11	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	20.49	2.76	18.88	3.45	5.30	1.38	1.61	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	35.76	6.31	9.68	3.16	10.31	1.68	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	21.61	2.65	11.82	3.67	2.45	0.00	1.83	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	30.25	3.65	14.16	1.50	6.65	1.50	1.50	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	28.90	4.00	8.22	2.45	6.00	0.67	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	14.02	2.19	10.07	1.31	3.72	1.53	1.75	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	20.28	6.08	5.58	2.53	1.52	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	13.26	3.31	4.97	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	15.22	2.17	6.25	5.71	3.26	1.63	1.36	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	22.64	2.94	8.23	2.94	6.47	2.06	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	29.44	3.27	2.18	1.09	2.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.61	1.44	8.65	0.48	1.92	1.44	1.44	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	22.41	4.40	8.40	2.00	7.60	1.20	0.80	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	37.02	1.37	4.11	1.37	0.00	1.37	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	14.02	2.50	7.51	2.00	2.50	0.50	1.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	77.46	4.08	4.08	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	24.96	2.19	8.32	3.07	1.75	1.31	3.07	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	35.32	3.31	1.10	3.31	1.10	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	57.63	6.40	5.76	4.48	1.28	0.00	2.56	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	28.01	3.47	11.16	3.72	3.72	0.25	5.70	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	20.88	2.78	4.87	2.78	2.78	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	90.60	17.68	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	36.24	3.08	11.62	4.44	1.37	2.39	4.10	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	29.76	4.81	1.75	3.50	2.63	0.00	1.75	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	75.99	7.10	4.62	1.07	0.71	1.07	1.07	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	40.12	4.49	7.29	4.49	5.05	1.40	3.93	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	29.93	7.07	7.48	2.49	3.33	2.08	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	64.68	6.41	1.17	5.83	1.17	0.00	1.75	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	28.36	6.33	4.52	2.41	1.51	0.30	2.11	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	41.74	8.35	9.60	4.59	4.59	1.67	3.76	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	86.63	14.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	34.17	6.46	5.54	1.85	4.62	0.92	1.85	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	38.70	6.26	7.97	2.28	2.28	2.85	1.71	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	62.46	5.53	5.25	2.07	0.83	1.38	2.49	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	41.72	3.63	6.74	3.37	1.81	0.78	2.33	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	57.05	7.29	8.15	5.58	3.43	0.86	2.57	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	66.06	5.72	1.91	2.54	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	34.96	4.00	4.00	4.00	2.40	0.53	1.87	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	60.76	4.79	19.76	7.18	1.50	2.10	1.20	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	52.69	4.94	5.09	3.25	0.71	0.28	2.83	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	31.53	2.23	6.69	1.91	2.87	0.64	4.78	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	43.12	7.96	11.72	2.21	5.31	0.66	4.42	1.11
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	79.25	8.34	3.41	1.90	1.14	1.14	2.65	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	42.62	5.40	9.09	2.56	1.70	1.14	2.56	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	43.51	3.44	11.80	4.92	3.44	0.98	3.69	1.97
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	94.49	9.12	3.26	1.96	1.30	0.65	0.00	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	49.69	4.12	8.82	2.35	1.76	0.59	2.06	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	50.17	9.80	16.43	6.05	4.04	1.15	1.15	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	65.94	10.30	19.78	5.77	0.41	1.65	1.24	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	54.79	7.44	12.51	5.36	2.68	0.60	2.08	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	0.00	0.00	3.77	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	42.77	7.13	10.69	1.78	8.91	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	94.96	11.17	13.80	7.56	5.91	0.99	2.63	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	51.55	3.16	12.62	8.42	9.47	0.00	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	71.96	11.66	13.44	7.51	7.31	1.38	0.40	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	54.02	13.97	22.35	8.38	19.56	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	79.24	8.64	11.64	7.14	12.02	0.75	2.25	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	42.88	7.72	13.32	5.06	11.19	2.13	0.27	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	62.21	5.54	14.93	3.51	4.75	0.90	1.47	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	49.36	6.63	19.15	3.68	5.16	1.47	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	85.74	8.43	9.53	7.33	4.76	0.73	1.83	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	57.56	9.33	15.56	7.78	10.89	4.67	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	37.41	2.67	11.76	2.67	1.60	0.53	3.21	2.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	46.37	7.73	7.73	11.59	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	61.61	9.09	9.09	6.06	2.02	1.01	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	34.57	6.75	5.90	2.11	8.01	0.84	1.69	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	1.36	17.71	5.45	2.72	0.00	2.72	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	19.07	1.27	22.89	0.00	1.27	1.27	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.96	0.00	12.96	0.00	0.81	0.00	4.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	28.70	1.51	13.59	1.51	1.51	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	68.52	5.71	91.36	11.42	0.00	0.00	17.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	6.52	185.96	9.79	3.26	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	57.03	4.75	19.01	0.00	9.50	0.00	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	12.55	0.00	50.20	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	11.85	4.74	1.72	0.22	0.00	0.43	3.66	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	8.36	5.23	0.52	0.00	0.00	0.00	4.18	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	12.01	6.67	2.00	1.33	0.00	2.00	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	11.69	4.59	1.25	1.25	0.00	0.00	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	37.84	12.55	3.99	2.28	0.00	0.19	10.27	2.85
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	76.60	4.79	1.60	3.19	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	10.20	2.72	0.68	0.68	0.00	0.00	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	25.73	1.84	9.19	0.00	0.00	0.00	25.73	9.19
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.21	5.02	0.00	0.42	0.00	0.00	0.84	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.97	6.97	1.63	1.63	0.00	0.70	1.63	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.97	8.11	1.89	0.81	0.00	0.00	3.51	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	11.98	7.57	1.05	1.05	0.00	0.00	3.57	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	0.00	0.00	0.00	0.00	0.00	0.00	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	11.42	11.42	0.50	0.99	0.00	0.00	3.47	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	15.97	5.14	1.62	0.27	0.00	0.00	4.06	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.28	4.76	0.68	0.23	0.00	0.00	1.81	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.47	6.21	0.65	0.65	0.00	0.00	1.80	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	11.12	7.29	4.56	1.64	0.00	0.36	3.28	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.14	6.37	0.53	0.00	0.00	0.00	2.12	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.00	2.40	1.20	1.80	0.00	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	37.08	9.19	7.55	0.33	0.00	0.00	7.55	3.94
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.08	4.88	1.63	0.00	0.00	0.16	1.30	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	14.82	8.29	2.29	1.59	0.18	0.18	3.53	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.25	2.81	0.00	0.70	0.00	0.00	1.41	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	14.25	7.36	1.84	0.46	0.00	0.00	2.76	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	14.14	6.43	0.96	0.32	0.00	0.00	3.86	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	47.59	7.59	4.83	0.00	0.00	0.00	9.66	3.79
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	15.17	7.59	2.53	0.00	0.00	63.21	15.17
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	12.92	5.57	2.67	0.22	0.00	0.00	2.45	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	9.31	2.96	1.27	0.42	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	14.48	9.26	0.95	0.71	0.00	0.47	3.32	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	8.16	3.00	0.86	1.29	0.00	0.00	3.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	72.22	18.06	0.00	9.03	0.00	9.03	45.14	27.08
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	16.33	7.66	2.00	0.00	0.00	1.00	1.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	8.12	5.86	1.35	0.45	0.00	0.00	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.56	5.16	0.00	0.00	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	14.86	9.29	0.00	0.93	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	12.86	3.78	1.51	1.14	0.00	0.00	5.30	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.10	3.58	0.33	0.33	0.00	0.00	0.98	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.02	4.79	0.44	0.87	0.00	0.00	1.74	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.02	7.24	0.00	0.90	0.00	0.00	2.26	2.71
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	12.35	8.82	0.88	0.88	0.00	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	11.97	6.65	0.00	0.00	0.00	0.00	1.33	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	11.41	6.45	0.50	1.49	0.00	0.99	3.47	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.51	4.98	0.77	0.00	0.00	0.00	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	15.73	8.77	1.21	0.30	0.00	0.60	6.05	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	12.82	8.40	1.77	1.99	0.00	0.44	1.77	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	7.45	6.78	0.00	0.00	0.00	0.00	0.68	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	5.11	0.00	0.00	0.00	0.00	30.66	15.33
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.15	7.93	2.44	0.61	0.00	0.00	1.22	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	15.42	6.29	0.31	0.63	0.00	0.00	0.63	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.22	6.36	1.82	0.30	0.00	0.00	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	12.66	3.96	0.00	0.00	0.00	0.00	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	35.14	5.67	2.27	0.00	0.00	0.00	12.47	7.94
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	5.06	5.06	0.00	0.00	0.00	50.58	35.41
Myoblast, donor1	11241-116D8	13.04	3.85	3.60	0.87	0.00	0.25	2.36	2.36
Myoblast, donor2	11322-117D8	13.23	5.95	0.77	0.96	0.00	0.00	4.03	1.53
Myoblast, donor3	11398-118D3	13.28	6.05	2.69	1.01	0.00	0.17	2.69	2.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	7.44	6.42	0.00	1.02	0.00	0.00	2.04	1.02
Natural Killer Cells, donor1	11230-116C6	18.45	7.07	0.62	3.69	0.00	0.00	0.92	0.31
Natural Killer Cells, donor2	11311-117C6	10.25	6.94	0.00	3.02	0.00	0.00	0.60	0.30
Natural Killer Cells, donor3	11387-118C1	14.72	7.36	0.92	3.31	0.18	0.00	0.18	0.18
Neural stem cells, donor1	11275-116H6	20.32	14.52	0.00	0.73	0.00	0.00	2.18	1.45
Neural stem cells, donor2	11352-117H2	17.33	21.18	0.00	0.00	0.00	0.00	1.93	1.93
Neurons, donor1	11494-119E9	10.24	11.38	0.00	4.55	0.00	0.00	6.83	3.41
Neurons, donor2	11574-120E8	11.45	9.03	0.00	1.54	0.00	0.00	4.84	2.64
Neurons, donor3	11655-122E8	18.09	9.04	0.00	1.64	0.00	0.00	1.64	0.82
Neutrophils, donor1	11233-116C9	50.11	7.42	0.93	2.78	3.71	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	31.89	2.90	2.90	0.00	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	54.36	10.38	2.44	7.94	6.11	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	11.75	8.43	0.00	0.12	0.00	0.00	3.80	2.26
Nucleus Pulposus Cell, donor2	11409-118E5	7.16	3.26	0.33	0.65	0.00	0.00	0.65	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	6.22	3.21	0.40	0.00	0.00	0.00	5.82	0.80
Olfactory epithelial cells, donor1	11933-125I7	9.77	6.06	0.00	1.24	0.00	0.00	1.79	0.96
Olfactory epithelial cells, donor2	11934-125I8	12.16	5.93	0.87	0.72	0.00	0.00	2.61	1.45
Olfactory epithelial cells, donor3	11935-125I9	9.19	5.79	0.00	0.68	0.00	0.00	1.14	0.91
Olfactory epithelial cells, donor4	11936-126A1	8.77	6.92	0.39	0.39	0.00	0.00	1.85	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	14.44	4.21	0.60	0.60	0.00	0.60	6.02	1.20
Osteoblast - differentiated, donor1	11276-116H7	10.42	5.10	0.43	0.43	0.00	0.43	2.55	1.28
Osteoblast - differentiated, donor2	11353-117H3	1.14	1.14	0.00	0.00	0.00	0.00	0.00	4.57
Osteoblast - differentiated, donor3	11425-118G3	4.97	1.86	0.62	0.62	0.00	0.62	3.10	1.86
Osteoblast, donor1	11277-116H8	9.19	4.30	0.00	1.76	0.00	0.00	1.76	0.98
Osteoblast, donor2	11354-117H4	8.43	2.81	0.70	0.70	0.00	0.00	3.51	0.70
Osteoblast, donor3	11426-118G4	8.18	6.93	0.00	0.36	0.00	0.00	3.02	0.71
Pancreatic stromal cells, donor1	11249-116E7	18.03	7.92	2.53	1.43	0.00	0.25	3.79	2.11
Pericytes, donor1	11491-119E6	5.23	1.89	0.11	0.22	0.00	0.00	1.11	0.45
Pericytes, donor2	11571-120E5	5.89	2.49	0.00	0.23	0.00	0.00	2.04	0.45
Pericytes, donor3	11652-122E5	8.75	3.87	0.20	0.41	0.00	0.00	2.03	0.41
Perineurial Cells, donor1	11499-119F5	11.53	7.80	0.11	0.34	0.00	0.00	5.09	1.70
Perineurial Cells, donor2	11579-120F4	11.04	6.16	0.18	0.46	0.09	0.00	7.27	1.01
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	45.58	14.66	0.96	3.19	0.64	0.00	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	27.18	12.49	2.94	2.20	3.67	0.00	0.24	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	22.65	9.45	1.42	1.94	2.33	0.26	0.00	0.13
Placental Epithelial Cells, donor1	11278-116H9	8.61	4.54	0.00	0.48	0.00	0.00	2.63	0.24
Placental Epithelial Cells, donor2	11355-117H5	7.76	2.22	0.00	1.11	0.00	0.00	4.44	2.22
Placental Epithelial Cells, donor3	11427-118G5	6.09	4.71	0.20	0.39	0.00	0.00	1.96	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.01	2.22	0.00	0.00	0.00	0.00	1.58	0.95
Preadipocyte - breast, donor1	11467-119B9	12.57	5.82	1.50	1.13	0.00	0.38	1.31	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	29.37	12.79	1.70	3.65	0.00	0.13	1.31	0.78
Preadipocyte - breast, donor2	11328-117E5	8.78	7.20	0.90	0.23	0.00	0.00	2.70	1.58
Preadipocyte - omental, donor1	11468-119C1	13.64	5.33	1.92	0.96	0.00	0.53	2.45	1.39
Preadipocyte - omental, donor2	11329-117E6	16.59	6.98	0.87	2.18	0.00	0.87	2.62	0.87
Preadipocyte - omental, donor3	11403-118D8	11.32	5.73	0.57	1.72	0.14	0.14	2.86	1.43
Preadipocyte - perirenal, donor1	11469-119C2	5.91	0.98	0.00	0.00	0.00	0.00	5.91	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	12.59	3.99	3.99	2.46	0.00	0.61	2.46	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	15.76	7.08	2.66	1.59	0.00	0.00	3.19	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	11.58	2.55	1.36	0.68	0.00	0.17	3.07	0.51
Preadipocyte - visceral, donor1	11280-116I2	17.88	7.73	4.19	1.40	0.00	0.28	3.26	1.68
Preadipocyte - visceral, donor2	11357-117H7	12.89	2.76	5.98	0.46	0.00	0.46	1.84	0.46
Preadipocyte - visceral, donor3	11429-118G7	11.70	3.45	1.36	0.42	0.00	0.00	7.31	1.88
Prostate Epithelial Cells (polarized), donor1	11253-116F2	11.16	9.05	0.15	1.36	0.00	0.00	5.43	0.60
Prostate Epithelial Cells, donor2	11331-117E8	10.02	2.84	2.44	0.41	0.00	0.41	1.76	0.14
Prostate Epithelial Cells, donor3	11404-118D9	7.16	1.47	10.29	0.24	0.00	0.12	0.18	0.18
Prostate Stromal Cells, donor1	11254-116F3	15.49	4.33	1.48	1.71	0.00	0.34	1.71	0.91
Prostate Stromal Cells, donor2	11332-117E9	17.21	5.56	2.15	1.08	0.00	0.00	2.69	1.61
Prostate Stromal Cells, donor3	11405-118E1	9.28	3.02	0.83	0.83	0.00	0.00	3.44	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	4.38	4.74	0.36	0.00	0.00	0.00	0.73	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	10.88	4.16	0.55	0.28	0.00	0.14	1.46	0.49
Renal Epithelial Cells, donor1	11517-119H5	3.55	4.57	0.00	0.51	0.00	0.00	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	6.40	3.56	0.00	0.00	0.00	0.00	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	10.59	4.76	0.11	0.21	0.00	0.00	1.38	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	2.72	0.00	0.00	0.00	0.00	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.89	2.83	1.08	0.00	0.13	0.13	4.72	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.55	2.66	0.00	1.11	0.00	0.00	5.33	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.99	2.66	0.00	0.67	0.00	0.00	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	5.72	3.30	0.00	0.22	0.00	0.00	1.10	0.22
Renal Mesangial Cells, donor2	11598-120H5	8.15	5.64	0.00	0.00	0.00	0.00	2.51	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.99	1.39	0.00	0.00	0.00	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	10.74	6.98	0.27	0.00	0.00	0.00	2.42	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.33	1.27	0.42	0.00	0.00	0.00	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	6.56	3.47	0.00	0.39	0.00	0.00	0.96	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	4.15	4.15	0.52	0.00	0.00	0.26	3.37	2.33
Retinal Pigment Epithelial Cells, donor1	11528-119I7	5.97	3.98	0.85	0.00	0.00	0.28	1.71	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	3.09	1.03	0.00	0.00	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	9.03	2.76	0.50	0.50	0.00	0.00	0.75	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	19.24	11.76	6.15	1.74	1.74	1.20	2.81	1.60
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	19.65	10.72	0.00	0.89	0.00	0.00	2.68	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	42.93	13.21	1.65	2.20	0.00	0.00	5.50	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	41.76	9.86	1.16	0.00	0.00	0.00	2.90	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	20.28	9.10	0.00	1.56	0.00	0.00	7.15	1.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	18.07	10.13	0.00	0.70	0.00	0.00	2.78	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	22.87	13.50	0.00	1.12	0.00	0.00	3.12	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	27.79	12.28	0.00	1.86	0.00	0.00	10.92	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	20.86	10.96	0.00	0.93	0.00	0.00	3.26	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	27.27	11.79	0.23	1.62	0.00	0.00	5.55	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	17.11	7.53	0.00	1.23	0.00	0.00	5.89	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	18.91	9.53	0.00	1.36	0.00	0.00	2.57	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	15.59	10.39	0.18	1.79	0.00	0.00	3.58	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	18.51	8.61	0.00	2.01	0.00	0.00	6.03	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	16.42	10.62	0.00	1.40	0.00	0.00	3.65	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	17.70	8.85	0.00	1.11	0.00	0.00	4.65	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	17.01	9.37	0.00	0.96	0.00	0.00	5.93	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	18.26	11.09	0.00	1.96	0.00	0.00	2.89	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	26.87	13.91	0.19	1.69	0.00	0.00	2.25	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	21.10	9.55	0.00	0.66	0.00	0.00	5.31	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	20.83	10.51	0.00	1.36	0.00	0.00	3.89	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	19.86	12.03	0.19	2.10	0.00	0.00	3.06	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	18.05	9.72	0.00	1.50	0.00	0.00	6.09	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	20.46	9.53	0.00	1.12	0.00	0.00	3.36	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	18.12	13.67	0.00	2.22	0.00	0.00	3.08	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	21.15	6.93	0.00	0.91	0.00	0.00	4.56	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	17.41	11.40	0.00	1.59	0.00	0.00	2.82	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	17.86	11.15	0.00	1.61	0.00	0.00	4.57	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	17.93	6.60	0.00	0.24	0.00	0.00	4.72	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	20.44	11.51	0.20	2.58	0.00	0.00	3.97	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	19.41	11.46	0.00	1.40	0.00	0.00	4.91	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	15.76	7.05	0.21	1.04	0.00	0.00	7.46	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	19.25	11.50	0.00	0.88	0.00	0.00	2.21	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	18.38	11.70	0.21	1.67	0.00	0.00	2.92	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	20.32	9.96	0.00	0.94	0.00	0.00	5.11	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	22.14	10.90	0.00	1.19	0.00	0.00	3.07	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	21.98	13.11	0.00	1.93	0.00	0.00	3.66	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	16.33	10.49	0.00	1.38	0.00	0.00	8.94	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	16.05	12.62	0.00	1.23	0.00	0.00	2.74	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	20.36	11.82	0.00	1.15	0.00	0.00	4.10	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	18.75	9.37	0.00	1.53	0.00	0.00	7.33	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	20.86	10.36	0.00	2.22	0.00	0.00	3.70	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	13.86	11.73	0.00	0.53	0.00	0.00	3.73	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	22.95	6.91	0.14	0.69	0.00	0.00	5.53	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	17.62	10.71	0.00	0.71	0.00	0.00	4.76	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	28.22	12.70	0.20	3.22	0.00	0.00	2.62	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.36	9.13	0.09	0.47	0.00	0.00	6.40	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	26.55	11.88	0.35	1.05	0.00	0.00	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	16.62	12.69	0.30	2.12	0.00	0.00	3.32	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.46	10.04	0.12	0.73	0.00	0.00	7.22	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	43.52	20.52	1.60	2.77	0.00	0.00	6.70	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	17.04	9.13	0.00	2.43	0.00	0.00	3.04	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	15.67	9.95	0.00	1.21	0.00	0.00	6.93	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	25.11	9.27	1.36	1.81	0.00	0.00	3.39	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	25.76	14.98	0.30	0.00	0.00	0.00	3.89	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	23.61	12.52	0.83	0.71	0.00	0.00	8.62	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	21.98	11.53	0.64	1.49	0.00	0.00	4.27	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	20.43	9.01	0.60	5.41	0.00	0.00	2.40	3.61
Schwann Cells, donor1	11498-119F4	3.95	2.63	0.00	0.19	0.00	0.00	1.50	0.38
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	4.38	4.60	0.66	0.22	0.00	0.00	1.53	0.88
Sebocyte, donor1	11220-116B5	17.53	9.31	20.82	0.55	0.00	2.74	4.38	0.00
Sebocyte, donor2	11301-117B5	11.49	3.68	5.51	0.00	0.00	0.46	3.22	0.92
Sebocyte, donor3	11378-118B1	7.21	3.50	5.15	0.41	0.00	0.62	1.65	0.21
Sertoli Cells, donor1	11255-116F4	14.91	11.60	0.00	3.31	1.66	0.00	4.97	6.63
Sertoli Cells, donor2	11333-117F1	8.47	8.47	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	12.93	6.51	0.09	0.88	0.00	0.00	1.85	1.50
Skeletal Muscle Cells, donor2	11358-117H8	1.45	0.72	0.00	0.00	0.00	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	15.05	7.52	0.00	0.00	0.00	0.00	3.34	0.84
Skeletal Muscle Cells, donor4	11451-119A2	9.43	5.03	1.41	1.41	0.00	0.00	7.38	1.73
Skeletal Muscle Cells, donor5	11455-119A6	10.55	4.61	0.30	0.45	0.00	0.00	7.58	1.34
Skeletal Muscle Cells, donor6	11459-119B1	12.31	5.85	0.46	1.08	0.00	0.00	4.16	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	15.75	6.30	0.88	0.38	0.00	0.00	5.67	1.89
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.84	5.71	0.00	0.43	0.00	0.00	3.42	1.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	13.49	7.74	0.40	0.99	0.00	0.00	3.37	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	14.15	8.93	0.00	1.26	0.00	0.00	2.61	1.94
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.96	0.72	0.72	0.72	0.00	0.00	0.00	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.47	4.54	0.00	0.14	0.00	0.00	3.16	0.28
Skin - palm, donor1	10286-104F7	29.55	26.86	0.00	0.00	0.00	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.19	2.02	0.43	0.43	0.00	0.29	4.18	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	67.88	13.09	5.73	1.64	0.00	0.00	4.91	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.05	2.47	0.00	0.52	0.00	0.00	4.41	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	14.73	3.61	2.50	0.42	0.00	0.28	1.25	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	12.66	4.22	1.13	0.28	0.00	0.00	1.69	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	74.43	24.10	1.69	0.85	0.00	0.42	3.59	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	8.54	3.37	0.82	0.45	0.00	0.07	0.45	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.01	2.47	0.62	0.00	0.00	0.00	4.01	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	16.23	5.56	0.44	1.56	0.00	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	9.41	3.53	0.00	2.35	0.00	0.00	2.94	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	13.26	4.20	1.99	1.33	0.00	0.22	1.55	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	13.78	4.33	3.15	0.79	0.00	0.39	3.54	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	8.50	4.64	0.00	0.00	0.00	0.00	1.55	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	10.01	1.00	0.00	0.00	0.00	0.00	3.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	11.58	3.86	0.13	0.27	0.00	0.00	1.60	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	9.75	5.98	0.00	0.22	0.00	0.00	0.89	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	12.29	4.10	0.13	0.38	0.00	0.00	3.33	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.77	3.58	1.63	0.98	0.00	0.00	3.58	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	13.88	6.20	1.77	0.00	0.00	0.00	6.50	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	8.26	2.42	1.28	0.57	0.00	0.00	3.27	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.55	2.44	0.49	0.33	0.00	0.00	1.14	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.66	4.57	2.13	0.00	0.00	0.00	1.52	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	9.60	6.06	0.51	0.51	0.00	0.00	2.02	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.68	1.43	0.48	0.00	0.00	0.00	0.95	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	9.73	2.95	1.03	0.59	0.00	0.44	2.95	2.06
Smooth Muscle Cells - Colonic, donor2	11320-117D6	8.61	4.74	1.08	1.29	0.00	0.22	5.38	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	8.82	4.51	1.15	0.73	0.00	0.10	4.51	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	13.15	3.56	3.40	1.24	0.00	0.00	1.55	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	4.31	0.00	0.00	0.00	0.00	3.23	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.85	3.59	1.79	0.90	0.00	0.30	4.18	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.44	2.73	0.00	0.68	0.00	0.00	2.39	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	14.53	7.62	0.47	0.79	0.00	0.00	4.32	1.41
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	17.71	5.84	1.71	0.70	0.00	0.20	1.41	1.41
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	13.20	4.32	2.73	0.23	0.00	0.46	5.01	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.25	3.62	0.60	0.60	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	15.37	6.89	1.32	1.59	0.00	0.00	6.62	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	21.04	6.66	0.13	1.20	0.00	0.00	6.26	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	11.65	5.26	0.38	1.38	0.00	0.00	4.76	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	10.15	4.06	3.80	0.76	0.00	0.00	3.30	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	14.02	6.78	0.75	1.06	0.00	0.00	2.71	1.36
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.75	2.25	0.75	1.50	0.00	0.00	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	9.05	2.58	0.00	0.00	0.00	0.00	5.17	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	12.09	9.77	0.47	0.93	0.00	0.00	3.26	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	12.62	5.05	0.00	1.01	0.00	0.50	2.02	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	12.85	2.19	0.31	0.31	0.00	0.00	3.45	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.72	1.47	1.18	0.00	0.00	0.00	0.88	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	13.75	7.66	1.08	0.75	0.00	0.00	5.00	1.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	10.74	4.20	0.93	0.00	0.00	0.00	3.74	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	11.95	3.60	0.72	0.14	0.00	0.00	2.59	1.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	11.73	5.86	1.02	0.25	0.25	0.00	2.04	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.84	3.76	0.00	0.38	0.00	0.00	3.01	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.16	5.87	0.00	0.56	0.00	0.14	6.15	1.40
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	10.81	4.19	0.08	0.34	0.00	0.00	4.11	1.09
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.38	0.00	0.00	0.48	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.03	4.16	0.73	0.24	0.00	0.00	1.22	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	12.81	4.86	1.77	0.88	0.00	0.22	6.85	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	9.07	3.80	1.76	1.46	0.00	0.00	2.34	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	7.00	3.89	0.58	0.97	0.00	0.00	1.55	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	10.31	2.64	2.91	0.79	0.26	0.79	1.85	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	17.48	4.46	1.12	0.74	0.00	0.00	3.35	2.60
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	6.47	1.80	3.95	0.72	0.00	0.00	1.44	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.94	1.70	1.70	0.57	0.00	0.00	0.85	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	14.97	3.54	1.58	2.36	0.00	0.00	3.15	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	12.44	3.30	0.25	0.51	0.00	0.00	3.81	1.78
Smooth muscle cells - airway, control, donor2	11967-126D5	9.58	4.79	0.80	0.40	0.00	0.00	2.80	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	10.45	2.93	1.25	0.00	0.00	0.00	2.09	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	6.88	3.67	1.38	0.00	0.00	0.00	5.04	1.83
Synoviocyte, donor1	11291-117A4	9.59	5.39	0.00	0.67	0.00	0.00	2.36	0.50
Synoviocyte, donor2	11368-117I9	7.04	4.19	1.17	0.00	0.00	0.17	5.36	1.84
Synoviocyte, donor3	11440-118H9	6.93	2.68	0.89	0.00	0.00	0.00	6.26	4.02
Trabecular Meshwork Cells, donor1	11532-120A2	7.86	3.57	0.00	0.71	0.00	0.00	2.50	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	3.96	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.86	3.47	0.00	0.00	0.00	0.00	0.23	1.39
Tracheal Epithelial Cells, donor1	11292-117A5	8.53	3.15	1.86	0.79	0.00	0.14	2.37	1.00
Tracheal Epithelial Cells, donor2	11369-118A1	8.89	2.71	0.77	0.00	0.00	0.00	1.93	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	6.87	2.29	0.57	0.00	0.00	0.57	0.57	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	21.90	13.90	5.66	1.48	1.23	0.37	2.21	1.35
Urethra, donor2	10319-105A4	21.58	28.77	0.00	1.80	0.00	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	7.17	2.13	0.00	0.00	0.00	0.00	2.39	0.00
Urothelial Cells, donor2	11600-120H7	6.41	2.80	1.20	0.40	0.00	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	5.96	3.67	0.23	0.23	0.00	0.23	1.38	0.23
Urothelial cells, donor0	11216-116B1	8.69	3.34	1.11	0.00	0.00	0.22	2.23	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	44.49	16.02	0.89	3.56	1.78	0.00	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	58.61	18.58	2.86	1.43	2.86	0.00	2.86	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	32.86	12.32	1.37	2.05	2.74	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	37.88	18.25	1.72	3.79	6.20	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	40.09	16.85	2.32	2.91	8.72	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	43.73	6.25	2.08	3.12	3.12	0.00	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	35.79	11.01	4.59	4.59	1.84	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	36.52	11.87	0.91	1.83	6.39	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	10.12	8.02	0.00	0.37	0.00	0.00	7.53	0.74
Wilms' tumor cell line:HFWT	10597-108E3	14.08	9.68	0.00	0.88	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	11.45	5.87	0.00	0.28	0.00	0.00	0.84	1.12
achilles tendon, donor2	10292-104G4	10.33	20.67	26.86	4.13	6.20	10.33	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	10.96	7.65	0.00	0.25	0.00	0.00	3.31	1.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	36.68	15.79	0.00	0.70	0.00	0.00	5.80	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	14.84	16.50	0.00	2.02	0.00	0.00	1.54	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	18.78	12.25	0.00	2.45	0.00	0.00	3.81	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	18.27	5.34	0.00	0.56	0.00	0.00	5.06	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	5.29	3.17	0.00	0.21	0.00	0.00	1.69	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	9.80	3.81	0.00	0.00	0.00	0.00	2.18	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	10.58	7.49	0.00	0.00	0.00	0.00	1.32	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	7.35	6.13	0.82	0.00	0.41	0.00	2.86	3.68
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	23.69	20.97	0.00	4.27	0.00	0.00	4.66	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	17.30	6.07	0.00	0.18	0.00	0.00	2.39	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	15.60	0.00	3.90	0.00	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	8.13	7.20	0.00	0.00	0.00	0.00	6.27	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	43.24	19.16	0.00	2.85	0.00	0.00	3.62	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	26.59	10.52	0.00	1.17	0.00	0.00	0.58	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	13.48	7.90	0.00	1.39	0.00	0.00	0.93	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	18.10	6.58	1.65	0.00	0.00	0.00	1.65	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	5.83	4.60	0.00	0.00	0.00	0.00	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	16.21	18.35	0.43	0.85	0.43	0.43	3.41	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	16.68	14.56	0.61	0.91	0.00	0.00	1.52	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	19.74	12.04	0.24	0.48	0.00	0.00	2.41	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	11.14	5.57	2.45	2.00	0.00	0.00	0.45	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	10.01	6.67	0.00	1.33	0.00	0.00	1.33	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	18.58	20.44	0.00	1.86	0.00	0.00	3.72	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	15.07	7.91	0.00	0.75	0.00	0.00	1.88	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	13.52	21.37	0.00	0.44	0.00	0.00	1.74	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	9.37	18.74	0.00	1.87	0.00	0.00	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	10.83	8.71	0.00	0.00	0.00	0.00	3.06	0.24
adipose tissue, adult, pool1	10010-101C1	22.03	11.48	13.50	1.71	1.86	1.24	2.33	0.78
adipose, donor1	10184-103D4	25.22	11.14	0.00	0.59	0.00	0.00	46.91	4.69
adipose, donor2	10185-103D5	6.08	6.49	0.00	0.00	0.00	0.00	1.62	0.41
adipose, donor3	10186-103D6	10.62	7.90	0.00	0.27	0.00	0.00	7.90	1.36
adipose, donor4	10187-103D7	6.07	4.33	0.00	0.87	0.00	0.00	3.47	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	9.47	8.36	0.00	0.16	0.00	0.00	1.42	1.10
adrenal gland, adult, pool1	10081-102A9	29.10	14.55	0.00	0.00	0.00	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	12.54	5.47	0.00	0.67	0.00	0.00	0.13	0.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	13.22	9.65	0.71	0.71	0.00	0.00	5.72	0.36
amniotic membrane cells, donor1	12235-129G3	9.97	10.67	0.46	0.23	0.00	0.23	1.62	2.09
amniotic membrane cells, donor2	12236-129G4	8.11	5.07	0.00	1.01	0.00	0.34	2.70	2.70
amniotic membrane cells, donor3	12237-129G5	13.26	14.73	2.36	0.00	0.00	0.00	0.29	1.18
amygdala - adult, donor10196	10167-103B5	18.97	9.49	0.00	0.00	0.00	0.00	2.37	2.37
amygdala, adult, donor10252	10151-102I7	21.29	20.07	0.41	1.62	0.00	0.00	1.22	6.49
amygdala, newborn, donor10223	10360-105E9	17.43	4.84	0.00	2.58	0.65	0.00	1.29	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	18.21	8.66	12.22	1.40	0.00	1.02	4.58	1.27
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	20.96	10.15	0.00	1.10	0.00	0.00	2.65	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	10.69	18.04	0.00	0.67	0.00	0.00	3.67	0.67
aorta, adult, pool1	10052-101G7	13.53	10.98	0.39	0.39	0.39	0.00	1.96	1.77
appendix, adult	10189-103D9	36.48	19.41	0.00	1.94	0.78	0.00	0.78	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	12.73	9.29	0.00	0.00	0.00	0.00	3.44	0.00
artery, adult	10190-103E1	8.15	13.59	0.00	0.00	0.00	0.00	2.72	2.72
astrocytoma cell line:TM-31	10425-106D2	24.48	17.82	0.58	0.72	0.00	0.00	5.79	0.87
b cell line:RPMI1788	10427-106D4	17.25	8.03	0.00	0.30	0.00	0.15	1.49	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	13.87	4.72	0.55	1.39	0.00	0.00	3.05	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	17.76	6.65	1.19	0.99	0.00	0.20	1.09	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	6.70	3.18	0.17	0.33	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	13.98	8.95	0.00	0.56	0.00	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	14.67	11.62	1.52	0.76	0.65	0.00	1.09	1.41
blood, adult, pool1	10053-101G8	17.72	4.43	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	5.99	0.00	1.71	0.00	0.00	6.85	2.57
bone marrow, adult	10192-103E3	37.79	12.15	6.75	2.02	0.67	0.67	2.02	2.70
brain, adult, donor1	10084-102B3	10.25	11.28	0.00	0.00	0.00	0.00	1.03	3.08
brain, adult, pool1	10012-101C3	12.69	13.81	0.22	0.89	0.00	0.00	2.34	2.90
brain, fetal, pool1	10085-102B4	18.70	21.37	0.00	2.67	0.00	0.00	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	15.20	17.84	0.00	0.99	0.00	0.00	0.66	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	9.99	7.74	0.00	0.25	0.00	0.00	1.37	0.25
breast, adult, donor1	10080-102A8	21.47	6.31	1.26	0.63	0.00	0.00	3.16	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	9.53	7.37	0.00	0.13	0.00	0.00	5.46	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	13.91	10.51	0.00	0.00	0.00	0.00	3.09	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	11.05	6.68	4.60	1.38	0.00	0.00	5.06	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	11.38	9.20	0.00	0.48	0.00	0.00	1.45	0.48
carcinoid cell line:NCI-H1770	10703-109H1	23.04	11.28	0.00	2.35	0.00	0.00	4.23	0.94
carcinoid cell line:NCI-H727	10735-110B6	6.45	8.86	0.22	0.55	0.00	0.00	2.52	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	16.16	13.94	0.00	0.00	0.00	0.00	4.12	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	14.11	9.85	0.00	1.33	0.00	0.00	1.33	0.27
caudate nucleus - adult, donor10196	10177-103C6	19.57	9.21	1.15	2.30	1.15	0.00	4.61	4.61
caudate nucleus, adult, donor10252	10164-103B2	22.09	15.73	1.34	0.50	0.00	0.17	3.18	3.51
caudate nucleus, adult, donor10258	10379-105H1	17.58	6.11	0.00	3.06	0.00	0.00	1.53	2.29
caudate nucleus, newborn, donor10223	10354-105E3	21.24	8.06	1.10	4.03	2.56	0.00	1.83	0.37
cerebellum - adult, donor10196	10173-103C2	32.05	20.39	0.00	0.00	0.00	0.00	2.91	5.83
cerebellum, adult, donor10252	10166-103B4	27.54	21.56	0.00	0.64	0.00	0.00	4.70	11.74
cerebellum, adult, pool1	10083-102B2	10.69	8.62	0.00	0.00	0.00	0.00	4.83	5.17
cerebellum, newborn, donor10223	10357-105E6	41.51	32.38	0.83	0.00	0.00	0.83	2.49	2.49
cerebral meninges, adult	10188-103D8	13.87	9.58	0.25	0.50	0.00	0.00	3.28	2.77
cerebrospinal fluid, donor2	10294-104G6	19.00	11.69	6.58	0.00	0.00	1.46	0.73	2.19
cervical cancer cell line:D98-AH2	10552-107I3	26.60	10.21	0.00	1.58	0.00	0.00	0.58	0.58
cervical cancer cell line:ME-180	10553-107I4	49.55	22.87	1.49	2.82	0.00	0.33	8.45	1.82
cervix, adult, pool1	10013-101C4	16.90	19.11	0.84	0.42	0.21	0.10	1.89	1.89
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	11.01	7.11	7.11	0.98	0.00	0.28	3.34	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	31.35	5.23	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	12.80	12.05	0.00	0.87	0.00	0.00	0.87	0.25
choriocarcinoma cell line:SCH	10785-110H2	10.35	8.01	0.00	0.12	0.00	0.00	2.22	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	8.78	7.35	0.00	0.00	0.00	0.00	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	5.70	6.84	1.14	0.28	0.00	0.28	3.13	1.99
chorionic membrane cells, donor2	12239-129G7	11.14	8.15	0.10	0.60	0.00	0.10	7.56	1.19
chorionic membrane cells, donor3	12240-129G8	18.68	10.44	2.20	0.00	0.55	1.10	6.04	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	8.08	3.03	0.00	0.00	0.00	0.00	7.07	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	9.22	9.22	0.19	0.38	0.00	0.00	5.19	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	23.02	9.08	0.00	0.42	0.00	0.00	2.32	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	22.60	6.16	0.00	0.77	0.00	0.00	1.03	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	24.43	9.92	0.00	0.97	0.00	0.00	1.21	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	26.67	9.37	0.20	1.43	0.00	0.00	1.83	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	18.85	13.25	0.00	0.29	0.00	0.00	1.18	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	21.89	10.43	0.00	1.82	0.00	0.00	2.87	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	5.94	5.71	1.14	0.23	0.00	0.00	2.51	0.46
clear cell carcinoma cell line:TEN	10636-108I6	5.21	3.47	0.35	0.17	0.00	0.00	1.21	0.35
colon carcinoma cell line:CACO-2	10513-107D9	10.43	6.04	0.00	0.55	0.00	0.00	3.48	2.01
colon carcinoma cell line:COLO-320	10420-106C6	22.42	18.62	0.00	0.76	0.00	0.00	4.56	0.76
colon, adult, donor1	10082-102B1	15.47	8.33	1.19	0.00	0.00	0.00	1.19	1.19
colon, adult, pool1	10014-101C5	17.74	10.81	1.41	1.18	0.59	0.00	4.00	1.53
colon, fetal, donor1	10070-101I7	12.98	6.80	0.00	0.62	0.00	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	13.75	13.75	0.00	9.17	0.00	0.00	4.58	4.58
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	21.25	6.37	0.00	2.55	0.00	0.00	1.70	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	18.26	5.89	0.00	1.21	0.00	0.00	3.62	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	18.33	11.14	0.00	2.40	0.00	0.00	3.24	1.13
corpus callosum, adult, pool1	10042-101F6	38.37	27.31	0.11	3.10	0.00	0.11	2.10	4.75
cruciate ligament, donor2	10295-104G7	32.42	8.92	11.35	0.81	3.24	3.24	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	17.66	16.85	0.00	0.00	0.00	0.00	4.01	2.41
diencephalon, adult	10193-103E4	9.60	8.40	0.00	1.20	0.00	0.00	0.96	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	14.70	7.58	0.00	0.23	0.00	0.00	2.98	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	13.59	9.74	0.00	0.51	0.00	0.00	2.56	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	20.46	2.41	0.48	0.24	0.00	0.00	2.65	0.96
ductus deferens, adult	10196-103E7	18.44	10.96	0.00	0.50	0.00	0.00	1.00	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	12.96	8.64	0.00	0.00	0.00	0.00	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	14.71	13.24	0.00	0.00	0.00	0.00	3.68	1.47
dura mater, adult, donor1	10041-101F5	36.01	16.27	0.50	3.39	0.74	0.00	1.24	1.16
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	17.10	5.55	0.00	2.44	0.00	0.00	1.33	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	7.02	3.73	0.00	1.29	0.00	0.00	1.43	1.43
embryonic pancreas cell line:1B2C6	10604-108F1	20.96	20.96	3.70	0.00	0.00	0.00	2.47	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	9.99	13.02	5.15	0.61	0.00	0.00	1.82	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	14.82	12.35	8.34	0.62	0.00	0.31	0.93	2.16
embryonic pancreas cell line:2C6	10603-108E9	18.39	19.70	2.63	0.00	0.00	0.00	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	5.36	4.02	0.00	0.34	0.00	0.00	1.34	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	11.96	13.96	9.06	1.09	0.00	0.72	1.63	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.01	5.15	0.00	0.32	0.00	0.00	0.48	0.16
epidermoid carcinoma cell line:A431	10426-106D3	16.90	9.12	0.33	1.00	0.00	0.00	2.11	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	22.33	10.01	0.99	2.53	0.00	0.22	3.74	0.88
epididymis, adult	10197-103E8	16.33	18.63	0.63	0.21	0.63	0.00	1.26	1.67
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	15.79	12.95	6.92	1.42	0.00	0.53	2.13	1.42
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.58	7.08	1.18	0.39	0.00	0.00	2.75	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	15.73	10.22	0.26	1.31	0.00	0.00	2.62	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	15.65	16.04	0.10	1.97	0.00	0.00	2.26	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	13.56	11.99	0.22	1.46	0.00	0.00	2.13	0.56
esophagus, adult, pool1	10015-101C6	13.70	10.41	1.81	0.11	0.42	0.00	1.17	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	26.93	17.53	0.00	1.00	0.00	0.00	2.76	1.00
eye - muscle inferior rectus, donor1	10272-104E2	19.32	21.73	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	21.04	10.52	12.63	0.00	6.31	0.00	2.10	2.10
eye - muscle medial, donor2	10299-104H2	26.79	17.86	0.00	0.00	0.00	0.00	0.00	2.98
eye - muscle superior, donor2	10297-104G9	26.37	12.61	4.59	1.15	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	24.78	8.74	10.20	0.00	7.29	0.00	4.37	0.00
eye, fetal, donor1	10054-101G9	13.47	11.44	0.25	0.00	0.00	0.00	5.08	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	11.67	6.28	5.77	0.38	0.26	0.13	3.46	0.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	16.86	4.04	6.41	0.24	0.00	0.47	4.75	0.71
frontal lobe, adult, pool1	10040-101F4	19.42	18.11	0.00	1.97	0.00	0.00	2.44	3.94
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	42.64	27.92	0.30	2.70	0.00	0.00	8.41	2.70
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	11.06	8.78	1.01	0.37	0.00	0.00	1.19	0.09
gall bladder, adult	10198-103E9	13.52	11.11	0.48	0.00	0.00	0.00	1.45	1.93
gamma delta positive T cells, donor1	11937-126A2	21.47	15.03	0.00	1.07	0.00	0.00	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	19.05	10.08	0.00	0.75	0.75	0.00	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	16.26	8.24	0.21	1.27	0.00	0.00	3.59	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	3.67	4.06	0.00	0.39	0.00	0.00	2.13	0.00
gastric cancer cell line:AZ521	10549-107H9	13.61	9.67	0.00	0.82	0.00	0.00	5.74	0.98
gastric cancer cell line:GSS	10560-108A2	19.22	2.75	0.00	0.00	0.00	0.00	4.58	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	14.16	9.60	0.00	0.00	0.00	0.00	3.20	1.14
giant cell carcinoma cell line:LU65	10487-107B1	9.52	2.87	7.92	0.57	0.00	0.34	0.69	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	14.70	10.92	6.02	0.42	0.14	0.56	1.82	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	16.21	13.97	0.00	0.50	0.00	0.00	1.75	1.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	12.46	9.50	3.59	1.16	0.00	0.21	1.69	1.06
glioblastoma cell line:A172, tech_rep2	10444-106F3	13.06	10.39	4.35	0.98	0.00	0.14	1.97	1.83
glioblastoma cell line:T98G	10485-107A8	15.78	9.05	0.00	0.88	0.00	0.00	1.55	0.88
glioma cell line:GI-1	10413-106B8	12.59	9.08	0.88	0.88	0.00	0.00	1.17	0.59
globus pallidus - adult, donor10196	10175-103C4	21.14	13.85	2.19	2.19	1.46	0.00	5.83	5.10
globus pallidus, adult, donor10252	10161-103A8	46.87	21.24	0.49	2.93	0.49	0.00	4.64	4.15
globus pallidus, adult, donor10258	10367-105F7	28.75	16.43	1.37	5.48	0.00	0.00	6.85	12.32
globus pallidus, newborn, donor10223	10364-105F4	15.45	7.46	0.00	1.07	0.53	0.53	1.07	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	53.84	24.47	0.00	7.34	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	5.23	0.00	0.00	0.00	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	11.20	13.76	0.64	0.32	0.00	0.00	2.88	0.32
hIPS +CCl2, biol_rep1	14383-156B9	4.59	2.30	0.00	1.38	0.00	0.00	19.74	1.84
hIPS +CCl2, biol_rep2	14384-156C1	1.83	2.74	0.00	0.00	0.00	0.00	14.18	0.91
hIPS +CCl2, biol_rep3	14385-156C2	6.44	3.22	0.00	0.00	0.00	0.00	14.17	2.58
hIPS, biol_rep1	14380-156B6	5.75	4.31	0.00	0.00	0.00	0.00	14.37	5.75
hIPS, biol_rep2	14381-156B7	4.12	2.06	0.00	0.00	0.00	0.00	14.40	0.69
hIPS, biol_rep3	14382-156B8	12.14	4.41	0.00	0.00	0.00	0.00	8.83	3.31
hairy cell leukemia cell line:Mo	10712-109I1	12.07	6.32	0.00	1.15	0.00	0.00	0.86	0.29
heart - mitral valve, adult	10205-103F7	14.35	8.97	0.00	0.90	0.30	0.00	1.79	2.39
heart - pulmonic valve, adult	10206-103F8	20.92	15.69	0.26	0.52	0.52	0.26	1.57	3.40
heart - tricuspid valve, adult	10207-103F9	14.99	14.15	0.00	1.67	0.83	0.00	6.66	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	10.61	10.20	0.61	0.20	0.61	0.00	3.67	1.63
heart, adult, diseased, donor1	10051-101G6	11.50	13.63	0.43	0.00	0.00	0.00	2.98	0.43
heart, adult, pool1	10016-101C7	6.67	5.75	0.46	0.92	1.15	0.00	2.30	2.53
heart, fetal, pool1	10046-101G1	23.82	15.61	0.10	1.03	0.31	0.00	3.49	1.54
hepatic mesenchymal tumor cell line:LI90	10778-110G4	8.64	5.86	0.00	0.62	0.00	0.00	2.16	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	13.08	7.14	0.00	0.00	0.00	0.00	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	13.04	7.73	0.22	0.88	0.00	0.00	4.75	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	12.50	7.53	0.12	0.49	0.00	0.00	5.95	1.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	13.14	7.38	0.00	1.11	0.00	0.00	5.36	0.81
hepatoma cell line:Li-7	10484-107A7	19.13	11.34	0.00	0.89	0.00	0.00	5.34	1.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	20.80	6.73	0.00	1.11	0.00	0.00	5.53	0.40
hippocampus - adult, donor10196	10169-103B7	28.39	18.93	0.95	0.00	0.95	0.00	0.95	8.52
hippocampus, adult, donor10252	10153-102I9	24.90	19.80	0.00	1.84	0.41	0.00	3.27	5.31
hippocampus, adult, donor10258	10374-105G5	11.95	7.97	0.00	1.00	0.00	0.00	4.48	3.49
hippocampus, newborn, donor10223	10363-105F3	10.22	7.05	0.00	1.76	0.70	0.00	0.70	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	17.70	5.49	0.00	1.22	0.00	0.00	18.92	4.27
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	7.85	3.73	0.00	0.98	0.00	0.00	5.11	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	10.41	4.82	0.00	0.76	0.00	0.00	5.33	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	8.46	5.07	0.00	0.56	0.00	0.00	7.89	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	10.07	8.78	0.00	0.00	0.00	0.00	8.00	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	9.87	6.45	0.00	0.00	0.00	0.00	5.69	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	14.89	11.97	0.00	0.29	0.00	0.00	5.55	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	12.93	8.83	0.00	1.08	0.00	0.00	3.88	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	10.84	9.59	0.42	0.83	0.00	0.00	4.17	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	7.58	7.34	0.00	0.95	0.00	0.00	2.84	2.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	9.64	8.04	0.32	1.13	0.00	0.00	4.02	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	7.41	8.08	0.00	0.00	0.00	0.00	7.41	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	8.92	2.82	0.00	0.94	0.00	0.00	5.01	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	6.88	7.86	0.00	0.00	0.00	0.00	9.33	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	13.96	6.98	0.00	0.87	0.00	0.00	9.60	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	11.45	8.40	0.00	0.57	0.00	0.00	6.49	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	6.98	4.80	0.00	0.00	0.00	0.00	9.16	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	13.49	3.50	0.00	0.50	0.00	0.00	12.49	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	10.36	6.41	0.00	0.19	0.00	0.00	4.14	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	9.09	9.09	0.00	0.00	0.00	0.00	6.37	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	9.71	5.95	0.00	0.00	0.00	0.00	4.39	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	7.51	5.55	0.00	0.33	0.00	0.00	3.76	1.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	6.97	7.84	0.00	0.29	0.00	0.00	6.97	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	11.36	5.68	0.00	0.30	0.00	0.00	5.38	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	9.98	4.43	0.00	0.74	0.00	0.00	4.80	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	7.13	5.99	0.00	0.57	0.00	0.00	7.13	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	12.66	6.53	0.00	0.82	0.00	0.00	13.07	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	7.75	7.39	0.00	1.06	0.00	0.00	12.32	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	9.19	3.80	0.00	0.63	0.00	0.00	5.70	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	7.57	7.87	0.00	0.91	0.00	0.00	7.26	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.41	11.38	0.00	0.00	0.00	0.00	8.27	3.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	3.32	14.61	0.00	0.00	0.00	0.00	4.65	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	8.98	7.44	0.00	0.26	0.00	0.00	4.62	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	6.90	6.39	0.26	0.51	0.00	0.00	6.90	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	7.57	12.12	0.76	0.76	0.00	0.00	3.79	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	11.09	8.40	0.00	0.34	0.00	0.00	3.70	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	6.76	3.38	0.00	0.00	0.00	0.00	7.25	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	8.47	3.12	0.00	0.89	0.00	0.00	9.36	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	9.27	7.80	0.00	0.98	0.00	0.00	6.83	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	7.03	7.03	0.00	0.31	0.00	0.00	5.81	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	45.55	32.53	0.00	0.00	0.00	0.00	74.82	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	17.87	6.62	0.00	0.66	0.00	0.00	9.60	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	15.87	12.59	0.00	1.09	0.00	0.00	1.64	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	12.30	8.69	0.00	0.72	0.00	0.00	1.45	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	11.39	7.12	0.00	0.71	0.00	0.00	3.56	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	8.35	5.97	0.00	0.00	0.00	0.00	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	11.24	10.02	0.00	0.41	0.00	0.00	5.96	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	7.81	4.85	0.00	0.27	0.00	0.00	4.04	0.81
immature langerhans cells, donor1	11904-125F5	15.01	4.36	0.73	1.70	0.24	0.00	1.70	1.94
immature langerhans cells, donor2	11905-125F6	19.01	8.71	0.79	1.58	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	21.95	17.22	0.09	1.14	0.00	0.00	2.46	3.69
keratoacanthoma cell line:HKA-1	10791-110H8	21.46	12.36	0.65	0.98	0.00	0.33	7.48	0.65
kidney, adult, pool1	10017-101C8	17.82	12.82	0.20	0.70	0.30	0.00	2.90	1.50
kidney, fetal, pool1	10045-101F9	18.60	17.97	0.07	0.42	0.21	0.00	2.41	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	19.74	12.78	6.96	0.85	0.00	1.56	4.26	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.94	4.56	0.83	0.41	0.00	0.00	2.63	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	12.84	11.01	2.57	1.83	0.00	0.00	0.73	0.00
left atrium, adult, donor1	10079-102A7	16.89	6.54	1.63	0.00	0.54	0.00	2.72	2.18
left ventricle, adult, donor1	10078-102A6	13.15	5.06	0.51	0.00	0.00	0.00	1.52	2.02
leiomyoblastoma cell line:G-402	10721-110A1	7.11	10.40	0.00	0.00	0.00	0.00	3.28	0.55
leiomyoma cell line:10964C	10569-108B2	9.70	3.23	3.59	1.08	0.00	0.36	0.36	0.72
leiomyoma cell line:15242A	10570-108B3	13.04	2.17	2.72	0.00	0.00	0.54	1.63	1.09
leiomyoma cell line:15425	10571-108B4	12.63	5.10	3.64	1.46	0.00	0.24	1.21	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	19.05	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	9.41	3.14	2.09	0.00	0.00	6.27	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	9.92	5.43	0.00	0.47	0.00	0.00	3.42	0.47
liposarcoma cell line:KMLS-1	10782-110G8	10.00	5.31	2.34	0.78	0.00	0.16	2.03	0.62
liposarcoma cell line:SW 872	10726-110A6	18.03	16.94	0.00	0.49	0.00	0.00	3.53	0.73
liver, adult, pool1	10018-101C9	13.94	7.29	0.81	0.97	0.32	0.32	4.05	0.81
liver, fetal, pool1	10086-102B5	7.53	3.76	0.00	0.94	0.94	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	25.81	13.71	0.00	1.75	0.87	0.00	1.46	2.48
locus coeruleus, adult, donor10252	10165-103B3	24.73	21.41	0.18	1.66	0.55	0.00	2.58	3.69
locus coeruleus, adult, donor10258	10375-105G6	13.82	9.59	0.00	2.54	0.00	0.00	1.97	2.54
locus coeruleus, newborn, donor10223	10362-105F2	32.39	11.78	0.84	3.79	0.84	0.00	1.26	3.79
lung adenocarcinoma cell line:A549	10499-107C4	6.64	3.46	0.00	0.42	0.00	0.00	2.08	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	18.61	16.55	0.00	0.00	0.00	0.00	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	15.69	15.16	0.00	0.26	0.00	0.00	1.85	0.53
lung, adult, pool1	10019-101D1	20.67	9.69	2.84	1.42	1.18	0.12	2.95	0.83
lung, fetal, donor1	10068-101I5	42.81	23.69	1.43	0.86	0.00	0.00	7.42	0.86
lung, right lower lobe, adult, donor1	10075-102A3	32.08	11.91	11.46	1.37	7.79	2.29	1.37	0.92
lymph node, adult, donor1	10077-102A5	31.72	10.89	0.47	3.79	4.26	0.00	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	17.97	6.36	0.00	0.00	0.00	0.00	1.53	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	24.00	7.85	0.00	0.60	0.00	0.00	4.68	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	25.48	11.04	5.10	6.80	0.00	0.85	2.55	0.00
mature adipocyte, donor1	12231-129F8	7.10	7.10	0.44	1.78	0.89	0.00	1.33	1.78
mature adipocyte, donor2	12232-129F9	7.68	6.43	0.21	0.42	0.00	0.00	1.04	4.15
mature adipocyte, donor3	12233-129G1	4.98	5.69	0.71	0.24	0.24	0.00	1.66	4.50
mature adipocyte, donor4	12234-129G2	10.00	12.11	0.00	0.00	0.00	0.00	0.79	2.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	22.87	12.63	0.00	0.00	0.00	0.00	1.91	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	15.79	6.77	0.00	3.38	0.00	0.00	1.13	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	20.05	18.21	0.37	1.47	0.00	0.00	3.68	4.41
medial frontal gyrus, adult, donor10258	10368-105F8	13.98	7.62	0.00	0.95	0.00	0.00	4.77	3.81
medial frontal gyrus, newborn, donor10223	10352-105E1	28.15	11.52	0.85	0.85	0.43	0.00	2.56	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	21.60	15.69	0.51	1.69	0.34	0.00	2.87	2.87
medial temporal gyrus, adult, donor10252	10156-103A3	26.53	19.95	0.64	2.33	0.85	0.00	4.88	4.24
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	9.63	0.00	0.00	0.00	0.00	0.00	7.71
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	86.12	14.35	0.00	0.00	0.00	0.00	43.06
medial temporal gyrus, newborn, donor10223	10353-105E2	13.64	6.10	0.00	1.08	0.00	0.00	1.44	1.79
medulla oblongata - adult, donor10196	10174-103C3	18.82	13.63	0.65	0.65	0.00	0.00	5.19	1.95
medulla oblongata, adult, donor10252	10155-103A2	25.08	19.35	0.31	2.17	0.46	0.15	2.17	5.42
medulla oblongata, adult, pool1	10038-101F2	25.06	17.71	0.41	1.55	0.41	0.08	2.29	3.67
medulla oblongata, newborn, donor10223	10361-105F1	17.71	10.76	0.35	1.39	0.00	0.00	1.74	2.43
medulloblastoma cell line:D283 Med	10838-111E1	19.04	6.86	0.00	0.44	0.00	0.00	2.44	0.22
medulloblastoma cell line:ONS-76	10759-110E3	15.77	10.27	0.00	1.10	0.00	0.00	4.40	0.86
melanoma cell line:COLO 679	10514-107E1	22.28	6.90	0.72	1.44	0.00	0.14	4.17	0.57
melanoma cell line:G-361	10465-106H6	35.83	8.96	2.71	0.00	0.00	0.00	1.90	1.36
meningioma cell line:HKBMM	10691-109F7	5.25	4.70	1.27	0.72	0.00	0.18	1.09	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	22.03	15.86	0.00	0.00	0.00	0.00	4.41	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	16.85	12.70	0.00	1.56	0.00	0.00	7.78	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	15.80	4.91	1.99	0.61	0.00	0.15	9.97	1.53
mesenchymal precursor cell - adipose, donor2	11748-123G2	9.63	4.36	2.18	0.18	0.00	0.55	4.54	1.45
mesenchymal precursor cell - adipose, donor3	11749-123G3	18.22	4.14	7.45	0.00	0.00	0.41	4.14	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	10.11	2.67	5.76	0.28	0.00	0.14	9.27	1.55
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	10.01	2.89	3.66	0.58	0.00	0.19	11.55	2.50
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.19	3.47	4.86	2.08	0.00	0.00	0.69	3.47
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.55	1.37	4.63	0.34	0.00	0.00	1.89	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.16	5.52	1.96	0.46	0.00	0.12	5.87	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	9.55	3.85	0.80	0.40	0.00	0.00	11.80	1.46
mesenchymal precursor cell - cardiac, donor4	11755-123G9	10.13	4.73	2.03	1.22	0.00	0.14	8.37	1.89
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	13.80	4.84	5.12	0.14	0.00	0.14	8.25	1.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	10.54	3.95	8.56	0.00	0.00	0.33	2.63	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	12.73	6.09	1.38	0.55	0.00	0.14	6.64	1.25
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	15.71	6.28	3.14	1.40	0.00	0.35	2.79	2.44
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	9.80	4.90	4.29	0.20	0.00	0.61	6.33	2.04
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	10.78	2.16	2.52	0.00	0.00	0.36	2.16	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	10.55	4.97	1.97	0.31	0.00	0.21	4.14	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.52	3.42	2.74	0.91	0.23	1.37	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	20.14	7.55	3.78	1.68	0.00	0.00	4.62	2.94
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	10.01	5.23	4.03	0.60	0.00	0.30	6.13	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.29	5.16	2.63	0.26	0.00	0.26	6.48	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	7.73	5.15	1.84	0.00	0.00	0.37	2.58	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.03	4.01	1.14	0.29	0.00	0.00	1.14	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	13.89	7.58	0.84	1.26	0.00	0.00	3.79	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	3.20	3.65	0.46	0.46	0.00	0.00	4.11	3.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	5.63	3.33	0.77	0.77	0.00	0.26	2.81	2.81
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	5.50	2.88	0.26	0.79	0.00	0.26	1.05	2.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	4.01	2.46	0.00	1.23	0.00	0.00	1.54	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	5.65	3.53	0.71	0.47	0.00	0.24	2.35	2.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	4.74	1.69	0.00	1.02	0.00	0.00	2.03	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	3.54	2.36	0.39	0.00	0.00	0.00	1.18	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	5.10	3.71	0.00	0.46	0.00	0.00	1.39	4.63
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	6.06	3.46	0.58	0.87	0.00	0.00	4.04	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	4.91	1.78	0.00	0.67	0.00	0.00	1.34	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	4.81	1.44	0.48	0.24	0.00	0.00	2.16	1.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	8.07	5.87	0.00	1.47	0.00	0.00	2.93	3.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.03	4.03	0.00	1.34	0.00	0.00	1.68	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	5.32	2.46	0.41	0.41	0.00	0.00	2.87	4.50
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	7.30	2.15	0.43	2.15	0.00	0.00	1.72	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2.73	0.00	0.00	0.00	0.00	0.00	2.73	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6.82	3.25	0.00	0.32	0.00	0.00	1.30	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	1.45	0.00	0.00	0.00	0.00	1.45	5.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.60	3.20	0.00	0.53	0.00	0.00	0.53	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	2.45	1.64	0.00	0.00	0.00	0.00	1.64	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	3.50	3.50	0.00	0.00	0.00	0.00	1.55	3.89
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	2.10	2.10	0.00	2.10	0.00	0.00	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	5.96	0.99	0.99	0.00	0.00	0.00	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	3.56	2.96	0.00	0.59	0.00	0.59	1.19	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	7.31	6.09	0.00	1.22	0.00	0.00	7.31	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.23	3.80	0.00	0.63	0.00	0.00	6.33	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	3.45	1.38	0.00	0.69	0.00	0.00	2.41	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	0.00	0.00	0.00	0.00	0.00	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	3.99	0.00	0.00	0.00	0.00	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	6.89	0.00	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.85	2.44	0.41	0.00	0.00	0.00	4.07	3.26
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	6.36	2.38	0.00	0.00	0.00	0.00	1.59	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	3.54	3.54	0.00	0.00	0.00	0.59	2.95	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	3.43	1.87	0.00	0.31	0.00	0.00	2.49	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	0.00	0.00	0.00	0.00	0.00	6.68	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	3.55	1.18	0.00	1.18	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	2.57	0.00	0.00	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.82	2.75	0.69	0.69	0.00	0.00	2.07	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.45	3.46	0.00	0.00	0.00	0.00	0.99	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	4.49	0.00	0.00	0.00	0.00	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	4.45	3.82	0.00	1.91	0.00	0.00	1.91	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	3.63	2.82	0.00	0.81	0.00	0.00	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	8.72	0.00	0.00	0.00	0.00	0.00	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	2.53	0.00	0.00	0.00	0.00	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	5.46	4.86	0.00	0.00	0.00	0.00	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	4.52	0.00	0.00	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	7.41	4.12	0.00	0.00	0.00	0.00	1.65	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	3.57	2.18	0.60	0.79	0.00	0.00	1.59	1.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	3.89	3.24	0.32	0.65	0.00	0.00	3.24	2.27
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	4.07	0.00	1.02	0.00	0.00	5.09	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	8.51	8.51	1.55	0.77	0.00	0.00	3.87	4.64
mesothelioma cell line:ACC-MESO-1	10493-107B7	17.01	10.16	9.21	0.24	0.00	0.00	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	8.34	8.34	0.70	1.85	0.00	0.23	3.48	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	12.82	17.09	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.52	7.40	9.56	1.23	0.00	0.92	1.75	1.03
mesothelioma cell line:Mero-25	10850-111F4	19.74	5.22	2.50	0.45	0.00	0.23	2.95	1.13
mesothelioma cell line:Mero-41	10851-111F5	14.91	8.80	1.22	0.98	0.00	0.49	2.44	0.98
mesothelioma cell line:Mero-48a	10852-111F6	16.83	6.64	0.22	0.44	0.00	0.00	1.99	2.21
mesothelioma cell line:Mero-82	10853-111F7	14.98	5.78	0.79	0.26	0.00	0.53	2.89	0.79
mesothelioma cell line:Mero-83	10854-111F8	13.11	5.62	2.72	0.51	0.00	0.51	3.74	0.68
mesothelioma cell line:Mero-84	10855-111F9	10.62	7.84	2.02	1.01	0.25	1.01	3.29	0.76
mesothelioma cell line:Mero-95	10856-111G1	11.39	9.73	2.28	0.21	0.00	0.41	1.45	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	14.41	4.31	13.09	1.33	0.17	1.82	1.82	1.16
mesothelioma cell line:NCI-H226	10846-111E9	15.75	5.25	5.43	0.54	0.00	1.09	3.44	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	19.47	11.10	11.62	0.51	0.00	0.34	1.88	0.51
mesothelioma cell line:NCI-H28	10845-111E8	11.71	3.05	0.00	0.25	0.00	0.00	0.51	0.00
mesothelioma cell line:No36	10857-111G2	12.40	7.50	1.63	1.30	0.00	0.00	1.30	0.00
mesothelioma cell line:ONE58	10858-111G3	15.72	7.04	13.82	0.81	0.00	0.81	2.44	0.27
migratory langerhans cells, donor1	11901-125F2	4.80	0.77	0.00	0.19	0.00	0.00	1.73	0.58
migratory langerhans cells, donor2	11902-125F3	5.86	2.44	0.00	0.12	0.00	0.12	0.37	0.12
migratory langerhans cells, donor3	11903-125F4	6.82	1.62	0.18	0.00	0.00	0.00	4.13	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	13.71	3.59	0.98	0.98	0.00	0.00	2.94	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	5.51	5.51	0.85	0.21	0.00	0.00	3.60	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	12.90	10.14	1.38	0.46	0.00	0.00	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	10.47	10.09	0.00	0.38	0.00	0.00	2.28	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	17.19	8.69	0.37	0.55	0.00	0.00	2.03	0.92
myeloma cell line:PCM6	10474-106I6	32.62	9.29	0.00	0.99	0.00	0.00	1.19	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	16.23	14.20	0.00	2.54	0.00	0.00	3.04	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	15.30	8.04	15.10	1.37	0.00	1.37	5.88	2.35
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.69	1.89	4.57	0.67	0.00	0.33	0.56	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.57	1.91	5.07	0.37	0.00	1.03	0.51	0.29
nasal epithelial cells, donor2	12227-129F4	11.04	4.42	2.21	0.00	0.00	0.55	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	18.40	11.73	0.00	0.46	0.00	0.00	3.91	2.07
neuroblastoma cell line:NB-1	10539-107G8	16.28	16.28	0.00	3.18	0.00	0.00	2.25	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	8.44	5.90	0.00	0.42	0.00	0.00	3.59	0.63
neuroblastoma cell line:NH-12	10555-107I6	11.74	12.86	0.00	0.37	0.00	0.00	6.15	1.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	9.01	14.00	0.00	0.95	0.00	0.00	2.37	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	12.35	14.41	0.00	1.11	0.00	0.00	2.22	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	6.44	4.83	0.00	0.60	0.00	0.00	2.62	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	9.54	18.44	0.00	1.27	0.00	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	18.90	6.92	0.00	0.00	0.00	0.00	3.19	0.53
neutrophil PMN, donor1	12133-128D9	14.87	0.00	14.87	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	79.68	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	66.29	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	20.46	13.53	0.00	0.68	0.00	0.00	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.81	8.01	0.00	0.00	0.00	0.00	7.20	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	8.98	7.05	0.00	1.60	0.00	0.00	4.81	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.34	3.94	0.53	0.79	0.00	0.00	2.89	0.79
nucleus accumbens, adult, pool1	10037-101F1	21.93	17.81	0.47	1.78	0.00	0.09	2.44	4.03
occipital cortex - adult, donor10196	10172-103C1	12.36	20.60	2.06	0.00	0.00	0.00	10.30	2.06
occipital cortex, adult, donor10252	10163-103B1	35.69	27.37	0.27	2.15	0.27	0.00	2.95	4.56
occipital cortex, newborn, donor10223	10355-105E4	11.65	8.37	0.36	1.82	0.36	0.36	1.09	0.73
occipital lobe, adult, donor1	10076-102A4	14.43	12.60	0.00	1.05	0.00	0.00	2.36	3.94
occipital lobe, fetal, donor1	10073-102A1	18.88	18.02	0.00	0.86	0.00	0.00	7.72	5.15
occipital pole, adult, pool1	10036-101E9	16.16	12.61	0.08	0.87	0.00	0.00	1.42	1.81
olfactory region, adult	10195-103E6	15.09	15.09	0.38	0.96	0.00	0.00	2.29	2.67
optic nerve, donor1	10277-104E7	22.01	22.01	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	18.45	9.45	0.80	0.46	0.00	0.00	4.67	2.16
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	14.29	9.89	0.55	0.55	0.00	0.00	4.40	0.96
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	21.33	11.68	1.02	0.68	0.00	0.00	5.76	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	9.70	4.97	0.81	0.46	0.00	0.00	6.47	1.16
osteoclastoma cell line:Hs 706.T	10704-109H2	13.52	7.06	0.29	2.06	0.00	0.00	1.47	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	7.47	4.67	0.00	1.87	0.00	0.00	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	5.51	5.30	0.00	0.42	0.00	0.00	1.06	0.64
ovary, adult, pool1	10020-101D2	12.93	12.49	0.87	0.70	0.44	0.09	3.67	1.66
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	10.45	3.85	0.37	0.92	0.00	0.00	3.12	0.37
pancreas, adult, donor1	10049-101G4	17.87	12.23	0.94	0.94	0.00	0.00	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	5.31	8.39	0.00	0.00	0.00	0.00	1.68	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	24.19	11.92	6.30	1.70	0.00	1.02	5.79	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	29.64	11.26	0.17	0.33	0.00	0.00	4.14	0.17
paracentral gyrus, adult, pool1	10035-101E8	19.31	15.38	0.00	0.73	0.09	0.00	1.92	2.93
parietal cortex, adult, donor10258	10373-105G4	12.48	6.61	0.73	0.73	0.73	0.00	8.81	1.47
parietal lobe - adult, donor10196	10171-103B9	18.81	13.17	0.00	0.00	0.00	0.00	1.88	2.82
parietal lobe, adult, donor10252	10157-103A4	20.24	17.10	0.00	0.86	0.00	0.00	2.85	3.42
parietal lobe, adult, pool1	10034-101E7	22.03	15.33	0.00	0.88	0.00	0.00	3.00	2.91
parietal lobe, fetal, donor1	10072-101I9	24.25	32.00	0.00	0.97	0.00	0.00	2.91	0.97
parietal lobe, newborn, donor10223	10356-105E5	15.70	9.72	0.37	2.62	0.00	0.00	1.87	1.12
parotid gland, adult	10199-103F1	14.80	8.02	0.00	1.85	0.00	0.00	0.62	0.00
penis, adult	10200-103F2	14.50	11.28	0.54	1.07	1.07	0.00	2.15	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	9.48	16.55	0.19	1.86	0.00	0.00	0.74	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	16.03	12.82	0.00	0.73	0.00	0.15	3.21	0.15
pineal gland - adult, donor10196	10179-103C8	39.35	21.93	0.65	0.65	0.00	0.00	1.94	1.29
pineal gland, adult, donor10252	10160-103A7	48.56	17.17	0.00	0.59	0.59	0.00	10.66	8.29
pineal gland, adult, donor10258	10377-105G8	27.59	12.54	0.63	0.00	0.63	0.00	2.51	3.76
pituitary gland - adult, donor10196	10180-103C9	32.38	27.32	0.00	1.01	0.00	0.00	5.06	3.04
pituitary gland, adult, donor10252	10162-103A9	46.38	38.05	0.52	1.56	0.52	0.00	10.94	4.17
pituitary gland, adult, donor10258	10378-105G9	34.90	16.17	0.00	0.00	0.85	0.00	5.11	3.40
placenta, adult, pool1	10021-101D3	16.77	19.03	3.12	1.18	0.43	0.43	1.83	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	16.02	11.92	0.00	0.53	0.00	0.00	1.85	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	16.81	13.54	2.02	0.62	0.00	0.00	1.40	3.11
pons, adult, pool1	10033-101E6	24.87	14.80	0.09	1.38	0.34	0.00	2.67	2.93
postcentral gyrus, adult, pool1	10032-101E5	18.92	14.12	0.09	2.09	0.00	0.00	2.70	3.57
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	4.18	0.00	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	0.00	0.00	0.00	0.00	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	15.15	10.05	0.29	1.46	0.00	0.15	3.50	0.44
prostate cancer cell line:PC-3	10439-106E7	14.52	9.62	0.18	1.09	0.00	0.00	2.36	0.54
prostate, adult, pool1	10022-101D4	14.06	13.88	1.45	0.73	0.09	0.09	2.18	1.72
putamen, adult, donor10196	10176-103C5	16.52	17.47	3.54	0.71	0.24	0.00	1.65	3.78
putamen, adult, donor10252	10152-102I8	7.84	5.88	0.00	0.00	0.00	0.00	1.96	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	9.84	12.02	0.00	0.00	0.00	0.00	2.19	6.56
putamen, adult, donor10258, tech_rep2	10372-105G3	10.63	7.73	0.00	0.72	0.00	0.00	1.21	3.38
putamen, newborn, donor10223	10365-105F5	30.74	14.99	3.00	2.25	0.75	0.75	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	12.80	10.47	1.45	0.29	0.00	0.58	2.91	0.00
rectum, fetal, donor1	10067-101I4	44.51	33.38	0.00	1.39	1.39	0.00	4.17	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	10.39	6.36	0.21	0.42	0.00	0.00	3.18	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	18.64	9.11	0.00	0.00	0.00	0.00	0.41	0.83
retina, adult, pool1	10030-101E3	21.27	21.07	0.10	1.39	0.00	0.00	3.48	1.19
retinoblastoma cell line:Y79	10475-106I7	10.39	8.83	0.00	0.52	0.00	0.00	7.01	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.33	9.59	0.00	0.98	0.00	0.00	3.32	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	20.81	14.90	0.00	1.12	0.00	0.00	5.91	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	12.88	8.34	0.00	1.52	0.00	0.00	3.03	1.52
salivary acinar cells, donor1	11771-123I7	10.20	3.40	2.59	0.00	0.00	0.65	0.97	0.16
salivary acinar cells, donor2	11772-123I8	10.33	5.51	0.28	0.28	0.00	0.00	1.65	0.69
salivary acinar cells, donor3	11773-123I9	20.52	9.93	3.31	2.65	0.00	0.00	0.66	2.65
salivary gland, adult, pool1	10093-102C3	23.45	11.44	1.14	0.57	0.00	0.00	1.14	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	10.88	4.22	89.03	0.42	0.17	10.62	1.43	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	13.40	3.41	73.47	0.24	0.00	9.52	3.64	0.35
seminal vesicle, adult	10201-103F3	26.98	18.52	0.00	0.53	0.00	0.00	3.17	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	18.95	11.17	0.00	0.49	0.00	0.00	2.92	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	4.28	7.05	2.77	0.50	0.00	0.25	4.28	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	11.04	10.04	0.00	2.01	0.00	0.00	4.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	9.27	12.76	0.00	0.27	0.00	0.00	2.96	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	14.37	7.07	0.00	1.11	0.00	0.11	0.66	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	14.71	7.74	0.13	0.13	0.00	0.00	2.32	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	9.22	21.99	0.00	0.00	0.00	0.00	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	10.91	11.15	0.60	0.60	0.24	0.12	2.52	1.68
skeletal muscle, fetal, donor1	10066-101I3	17.09	11.06	0.00	0.00	0.00	0.00	0.00	3.02
skin, adult, donor1	10074-102A2	0.00	13.57	0.00	0.00	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	27.77	23.36	0.00	0.63	0.00	0.00	1.89	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	18.01	15.01	0.00	0.67	0.00	0.00	10.01	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	14.18	10.40	0.00	1.26	0.00	0.00	10.09	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	7.32	9.83	0.00	0.77	0.00	0.00	2.31	3.66
small cell lung carcinoma cell line:LK-2	10541-107H1	19.94	12.36	0.00	0.82	0.00	0.00	2.31	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	13.03	7.56	0.00	0.48	0.00	0.00	1.45	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	18.96	9.59	0.00	0.44	0.00	0.00	8.28	1.53
small intestine, adult, pool1	10024-101D6	20.54	15.53	0.60	0.72	0.72	0.00	1.07	1.43
small intestine, fetal, donor1	10064-101I1	15.23	9.58	0.00	0.74	0.25	0.00	3.69	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	16.41	16.93	0.00	0.00	0.00	0.00	1.54	1.54
smooth muscle, adult, pool1	10048-101G3	9.56	10.08	1.29	0.26	0.00	0.00	4.14	2.07
somatostatinoma cell line:QGP-1	10781-110G7	22.51	7.77	0.00	0.00	0.00	0.00	1.07	0.27
spinal cord - adult, donor10196	10181-103D1	34.41	18.12	0.23	2.06	0.23	0.00	1.84	2.75
spinal cord, adult, donor10252	10159-103A6	42.98	20.11	0.39	1.18	0.39	0.00	6.31	7.49
spinal cord, adult, donor10258	10369-105F9	25.60	17.29	0.00	0.69	0.69	0.00	10.38	11.07
spinal cord, fetal, donor1	10056-101H2	17.08	15.86	0.61	1.83	0.00	0.00	3.66	4.88
spinal cord, newborn, donor10223	10359-105E8	43.63	20.66	1.38	4.13	0.00	0.00	3.21	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	19.71	5.38	0.45	1.49	0.00	0.00	2.24	0.75
spleen, adult, pool1	10025-101D7	40.42	13.33	1.65	2.64	5.40	0.11	1.98	0.44
spleen, fetal, pool1	10044-101F8	40.44	18.43	0.87	2.46	2.94	0.00	1.59	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	14.70	4.97	0.00	0.62	0.00	0.00	1.14	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	24.87	22.79	1.71	0.76	0.00	0.00	2.85	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	10.48	5.94	0.00	0.00	0.00	0.00	2.45	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	28.54	7.43	26.19	1.95	0.00	0.78	6.25	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	15.31	9.00	8.33	0.45	0.00	0.11	4.73	1.24
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	7.20	2.97	0.00	0.00	0.00	0.00	2.97	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	14.38	8.04	2.54	0.42	0.00	1.27	0.42	0.00
stomach, fetal, donor1	10062-101H8	17.09	24.56	0.00	0.00	0.00	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	30.19	14.81	0.00	1.14	0.00	0.00	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	29.70	20.77	1.04	4.15	0.21	0.00	3.12	4.98
substantia nigra, adult, donor10258	10371-105G2	18.10	8.28	0.00	0.00	0.52	0.00	7.24	3.62
substantia nigra, newborn, donor10223	10358-105E7	28.26	10.60	0.00	1.41	0.00	0.00	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	15.36	13.30	0.00	0.23	0.00	0.00	7.11	2.52
temporal lobe, adult, pool1	10031-101E4	16.78	13.39	0.00	0.68	0.00	0.00	2.03	3.56
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	19.23	19.94	0.00	0.71	0.00	0.00	4.99	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	13.63	12.31	0.00	1.32	0.00	0.00	2.20	3.96
tenocyte, donor1	11763-123H8	8.03	5.93	0.00	0.35	0.00	0.00	3.49	1.40
tenocyte, donor2	11765-123I1	6.49	3.05	1.53	0.38	0.00	0.00	6.87	5.72
tenocyte, donor3	11768-123I4	6.30	3.71	1.48	0.74	0.00	0.00	4.82	2.22
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	14.11	7.14	0.00	0.68	0.00	0.00	4.76	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	8.17	10.79	0.00	0.77	0.00	0.00	10.33	1.08
teratocarcinoma cell line:PA-1	10807-111A6	10.85	8.52	0.00	0.77	0.00	0.00	3.41	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	10.03	6.60	0.00	0.38	0.00	0.00	5.97	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	9.83	9.83	0.00	0.00	0.00	0.00	2.65	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	14.40	6.65	1.09	0.33	0.11	0.11	5.13	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	20.84	15.63	0.00	0.00	0.00	0.00	2.93	0.65
testis, adult, pool1	10026-101D8	11.70	7.52	0.86	0.21	0.11	0.00	2.90	1.40
testis, adult, pool2	10096-102C6	9.47	13.08	0.45	0.45	0.00	0.00	0.45	0.45
thalamus - adult, donor10196	10168-103B6	34.22	12.14	1.10	2.21	0.00	0.00	8.83	0.00
thalamus, adult, donor10252	10154-103A1	30.01	20.79	0.31	3.13	0.31	0.00	3.75	3.91
thalamus, adult, donor10258, tech_rep1	10370-105G1	10.78	9.24	0.00	0.00	0.00	0.00	3.08	20.02
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.35	7.41	0.00	0.66	0.00	0.00	2.47	3.29
thalamus, newborn, donor10223	10366-105F6	23.01	4.60	0.58	1.73	0.00	0.00	1.73	1.15
throat, adult	10209-103G2	20.47	12.98	1.00	0.50	0.50	0.00	3.50	2.00
throat, fetal, donor1	10061-101H7	21.63	22.24	0.00	0.61	0.30	0.00	3.05	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	15.90	11.13	0.00	0.40	0.00	0.00	2.78	0.79
thymus, adult, pool1	10027-101D9	29.43	21.08	0.00	1.39	0.00	0.10	2.39	0.40
thymus, fetal, pool1	10043-101F7	37.20	24.83	0.94	3.84	0.52	0.00	3.22	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	9.31	7.58	5.72	0.80	0.13	0.27	1.99	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	21.65	16.62	1.54	1.54	0.00	0.14	3.35	0.56
thyroid, adult, pool1	10028-101E1	12.32	14.56	0.65	0.65	0.47	0.19	4.20	1.21
thyroid, fetal, donor1	10060-101H6	10.55	21.09	0.00	1.05	0.26	0.00	1.32	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	30.80	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	13.95	9.07	0.93	0.23	0.00	0.23	1.63	2.09
tongue, fetal, donor1	10059-101H5	11.43	12.61	0.39	0.39	0.00	0.00	1.97	2.36
tonsil, adult, pool1	10047-101G2	33.06	20.04	0.00	1.40	0.00	0.10	1.00	0.90
trachea, adult, pool1	10029-101E2	20.70	11.53	1.23	1.31	0.98	0.16	3.84	1.55
trachea, fetal, donor1	10058-101H4	10.39	12.69	0.00	0.38	0.38	0.00	3.08	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	14.53	6.02	0.35	1.77	0.00	0.00	1.06	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	21.48	9.22	0.91	2.63	0.00	0.00	5.47	1.52
transitional-cell carcinoma cell line:JMSU1	10492-107B6	22.88	14.26	5.80	1.10	0.00	0.63	2.82	0.63
tridermal teratoma cell line:HGRT	10694-109G1	13.32	13.32	0.00	0.00	0.00	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	9.31	8.80	0.93	0.17	0.00	0.00	2.37	0.34
umbilical cord, fetal, donor1	10057-101H3	12.52	14.61	2.09	0.00	0.00	0.00	6.26	0.00
uterus, adult, pool1	10100-102D1	18.94	18.09	0.17	0.34	0.00	0.00	3.92	2.05
uterus, fetal, donor1	10055-101H1	19.45	9.73	0.00	1.54	0.00	0.00	2.56	0.51
vagina, adult	10204-103F6	14.86	7.11	3.23	0.65	0.65	0.00	2.58	1.94
vein, adult	10191-103E2	19.73	9.21	0.88	1.10	0.00	0.00	1.75	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	13.35	4.27	0.00	0.27	0.00	0.00	0.53	1.34